485
7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8668 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2011. Reproduction is authorised provided the source is acknowledged. 1 September 2011 EMA/721630/2011 Patient Health Protection Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004 Chapter 4: Structured substance information Version 2.0 Date of coming into force: 1 September 2011

Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8668 E-mail [email protected] Website www.ema.europa.eu

An agency of the European Union

© European Medicines Agency, 2011. Reproduction is authorised provided the source is acknowledged.

1 September 2011 EMA/721630/2011 Patient Health Protection

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004 Chapter 4: Structured substance information

Version 2.0

Date of coming into force: 1 September 2011

Page 2: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 2/485

Table of Contents

4. Structured Substance Information ..........................................................3 4.1. Introduction.......................................................................................................3 4.1.1. Controlled Vocabularies ....................................................................................3 4.1.2. Naming Conventions ........................................................................................4 4.2. The Structured Substance Information Overview.....................................................4 4.2.1. The Structured Substance Information for Chemicals ............................................5 4.2.2. The Structured Substance Information for Proteins ...............................................6 4.2.3. The Structured Substance Information for Nucleic Acids ........................................7 4.2.4. The Structured Substance Information for Polymers..............................................8 4.2.5. The Structured Substance Information for Structurally Diverse Substances ..............9 4.2.6. The Structured Substance Information for Mixtures............................................. 10 4.2.7. The Structured Substance Information for Specified Substance Group 1................. 11 4.2.8. The Structured Substance Information for Specified Substance Group 2................. 12 4.2.9. The Structured Substance Information for Specified Substance Group 3................. 13 4.3. The Structured Substance Information Data Element Description............................. 14 4.3.1. SSI for Chemicals .......................................................................................... 14 4.3.2. SSI for Proteins ............................................................................................. 58 4.3.3. SSI for nucleic acids..................................................................................... 123 4.3.4. SSI for Polymers.......................................................................................... 182 4.3.5. SSI for Structurally Diverse Substances .......................................................... 256 4.3.6. SSI for Mixtures........................................................................................... 328 4.3.7. SSI for Specified Substance Group 1............................................................... 387 4.3.8. SSI for Specified Substance Group 2............................................................... 426 4.3.9. SSI for Specified Substance Group 3............................................................... 455

Page 3: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 3/485

4. Structured Substance Information

4.1. Introduction

The Structured Substance Information (SSI) refers to the data elements that describe

detailed characteristics of the substance(s), which are ingredients of medicinal products.

An SSI file shall be created for each substance, which is an ingredient of a medicinal

product.

The SSI file shall be incorporated in the XEVPRM as outlined in chapter 3 published at

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum

ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410

138.

The set of characteristics that shall be provided in the SSI are based on the type of

substance class specified in the XEVPRM. The classification of the substance shall be based

on the principles outlined in the Annex published at

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum

ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410

138.

4.1.1. Controlled Vocabularies

The provision of certain information within the Structured Substance Information (SSI) is

based on the use of Controlled Vocabularies (CVs) and reference sources. The CVs to be

used are outlined in chapter 4.1. . For each data element where a CV applies, the name of

the CV that shall be used is described in the CV reference column in square brackets.

The CVs and the examples of reference sources are published at

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum

ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410

138

The CVs contain the following information:

List-name referring to the name of the CV, which is referenced throughout the

detailed guidance as applicable.

Term-ID referring to the unique identifier associated with each term of the CV.

Term-name (English) referring to the name of the controlled term in English.

Examples of Reference Sources are provided, where applicable.

Latin-name referring to the name of the controlled term in Latin, where applicable.

Synonym 1, 2 referring to the columns in the table that are repeated to describe

any other name or common name or synonym associated with the English term.

Description referring to the description of the term, where applicable.

The CVs will be regularly updated und new versions will be published at

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum

Page 4: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 4/485

ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410

138.

4.1.2. Naming Conventions

The provision of substance and specified substance names within the XEVPRM and the SSI

relies on the use of various reference sources and conventions for the naming of

substances. Instructions on the naming conventions and examples of reference sources

are published at

http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/docum

ent_listing_000336.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac0580410

138.

4.2. The Structured Substance Information Overview

The characteristics to be defined for each substance class are specified in the chapters 4.1.

Depending on the nature of the substance, each substance shall be described based on the

3.

ned in chapter 4.3.5.

pecified Substance – Group 3 - characteristics are outlined in chapter 4.3.9.

following substance classes:

Chemical - characteristics are outlined in chapter 4.3.1.

Protein - characteristics are outlined in chapter 4.3.2.

Nucleic Acid - characteristics are outlined in chapter 4.3.

Polymer - characteristics are outlined in chapter 4.3.4.

Structurally Diverse Substance – characteristics are outli

Mixture - characteristics are outlined in chapter 4.3.6.

Specified Substance – Group 1 - characteristics are outlined in chapter 4.3.7.

Specified Substance – Group 2 - characteristics are outlined in chapter 4.3.8.

S

Page 5: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.1. The Structured Substance Information for Chemicals

Figure 1 –Structured Substance Information (SSI) Chemical

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 5/485

Page 6: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.2. The Structured Substance Information for Proteins

Figure 2 - Structured Substance Information (SSI) Protein

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 6/485

Page 7: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.3. The Structured Substance Information for Nucleic Acids

Figure 3 -Structured Substance Information (SSI) Nucleic Acid

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 7/485

Page 8: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.4. The Structured Substance Information for Polymers

Figure 4 - Structured Substance Information (SSI) Polymer

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 8/485

Page 9: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.5. The Structured Substance Information for Structurally Diverse Substances

Figure 5 - Structured Substance Information (SSI) Structurally Diverse Substance

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 9/485

Page 10: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.6. The Structured Substance Information for Mixtures

Figure 6 - Structured Substance Information (SSI) Mixture

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 10/485

Page 11: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.7. The Structured Substance Information for Specified Substance Group 1

Figure 7 - Structured Substance Information (SSI) Specified Substance Group 1

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 11/485

Page 12: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.8. The Structured Substance Information for Specified Substance Group 2

Figure 8 - Structured Substance Information (SSI) Specified Substance Group 2

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 12/485

Page 13: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

4.2.9. The Structured Substance Information for Specified Substance Group 3

Figure 9 - Structured Substance Information (SSI) Specified Substance Group 3

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 13/485

Page 14: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 14/485

4.3. The Structured Substance Information Data Element Description

4.3.1. SSI for Chemicals

For chemical substances the SSI shall be based on the following data elements:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

substance

SUB

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).

Page 15: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 15/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

Substance_id

COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_Clas

COM.2.CV Type of substance based on a controlled vocabulary.

CV

Y Text 250

Page 16: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 16/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

sification

EXAMPLE: Single, Mixture

[Substance Class]

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Y

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes.

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have

Page 17: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 17/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: eng – English deu (T) - German

alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 18: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 18/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Official_name_status

ON.2.CV The status of the official name shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary.

CV [Domain]

Y Text 250

Page 19: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 19/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Human Pharmaceutical

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be

Y

Page 20: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 20/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE:

N/A N text 2500

Page 21: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 21/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

substance_code (0..n)

COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.

N

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_sy SC.4.CV The status of the code system CV Y text 250

Page 22: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 22/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

stem_status

shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

[Status]

Code_system_change_date

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be

Y

Page 23: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 23/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE:

N/A N text 2500

Page 24: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 24/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

version (1..n)

COM.VER The version section This section shall provide information on the version of the substance.

Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified.

N/A

N text 4000

Page 25: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 25/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

The field will be left empty when first insert of substance.

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship

Y

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Page 26: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 26/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field.

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Page 27: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 27/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

Substance_classification_code

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.

N alphanumeric

250

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Page 28: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 28/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:

N/A N text 2500

Page 29: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 29/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Encycl. 3: 429 (1792)

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described.

CV [Substance Name]

N Alphanumeric

12

Page 30: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 30/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity

N text 250

Page 31: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 31/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Operator]

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.8 The higher limit value of the N Nume 10

Page 32: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 32/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_numerator_value

substance shall be specified, where available.

ric

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Page 33: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 33/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Page 34: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 34/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a

N This section does not apply when Substance_classification_type is

Page 35: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 35/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 4000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_ GN.RS The reference source section Y

Page 36: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 36/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

source (1..n)

This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 37: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 37/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID”

CV [Substance Name]

N Alphanumeric

12

Page 38: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 38/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source

RS.2.CV The type of the reference source shall be specified based

CV

Y text 250

Page 39: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 39/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_type on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance.

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance

Page 40: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 40/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor

Group 2 and Specified substance group 3.

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_o TRG.4.CV The type of target organism CV N Text 250

Page 41: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 41/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

rganism_type

shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

[Organism type]

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane

CV [Target type]

N Text 250

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Page 42: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 42/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Structure (0..n)

SING.STR The structure section The structure of the substance shall be described, where applicable

N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.

Structural_represe

STR.1.CV The type of the structural representation shall be

CV

Y Text 250

Page 43: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 43/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ntation_type

described based on a controlled vocabulary. EXAMPLE: InChI, mol file

[Structural Representation Type]

Structural_representation

STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.

N/A Y Alphanumeric

4000

Structural_representation_attachment

STR.3 A copy of the structural representation shall be provided.

N .jpeg

Stereochemistry

STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.

CV [Stereochemistry]

Y Text 250

Page 44: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 44/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Optical_activity

STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)

CV [optical activity]

Y CV 250

Molecular_formula

STR.6 The molecular formula shall be provided. The molecular formula shall be specified with all the characters in capital letters.

N/A N Text 2000

Isotope (0..n)

STR.ISO The isotope section The isotope shall be described in this section, where applicable.

N

Nuclide_id

ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV.

CV [Substance Name]

N alphanumeric

12

Page 45: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 45/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Nuclide_name

ISO.2 The name for the nuclide shall be provided.

CV [Substance Name]

Y Text 4000

Substitution_type

ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown

CV [Substitution Type]

Y Text 250

Chemical (0..1)

SING.CHM The chemical substance section This section further defines the identifying characteristics of a chemical substance.

The section is mandatory if Substance_type_cv= Chemical

Page 46: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 46/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Stoichiometric

CHM.1 The stoichiometric characteristics shall be specified based on a controlled vocabulary.

Yes/ No

Y Boolean

Comment

CHM.2 Any comment can be provided in this field, if necessary.

N/A N 4000

reference_source (1..n)

CHM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.

CV [Source

Y text 250

Page 47: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 47/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Regulatory submission

Class]

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

non_stoichiometric (1..1)

CHM.NS This section provides the non-stoichiometric characteristics of the chemical substance.

N

This section is mandatory when Stochiometric value= no

Number_of_moieties

NS.1 The number of moieties specified shall be provided. Non-stoichiometric chemical substances shall have at least two moieties.

N/A

Y Numeric

4 The numeric value shall be always ≥ 2 The value is automatically calculated.

Page 48: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 48/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Each moiety shall be represented by a chemical structure.

Moiety (2..n)

NS.MOT The moiety section shall be provided. The moiety section serves for the description of both the moiety and the other fragment constituting the substance. EXAMPLE: Abacavir Sulphate Abacavir and sulfate shall be described separately based on this section characteristic.

Y The section is repeatable. The number of available section is = to the value given in Number_of_moieties.

Moiety_Role

MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate

CV [Role]

Y text 250

Moiety_name

MOT.2 The name of the moiety shall be provided.

CV [Substance

Y Text 4000

Page 49: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 49/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.

Name]

Moiety_id

MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Amount_type

MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount

MOT.AMT The amount section N

Page 50: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 50/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..1) Quantity

Operator AMT.1.CV CV

[Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanumer

250

Page 51: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 51/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

specified, where available.

[Unit Prefix] ic

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 52: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 52/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Property (0..n)

NS.PROP The property section The characteristics of the property shall be described.

N

Property_type

PROP.1.CV The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical,

CV [Property Type]

Y Text 250

Page 53: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 53/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

enzymatic, immunological

Property_name

PROP.2.CV The name of property shall be specified based on a Controlled Vocabulary.

CV [Parameter]

Y Text 250

Substance_id

PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_name

PROP.4 The name of the substance related to a defining property

CV

N Text 4000

Page 54: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 54/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified

[Substance Name]

Amount_type

PROP.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Amount (1..1)

PROP.AMT The amount section Y

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numer

AMT.4.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanumer

250

Page 55: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 55/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ator_unit_prefix

specified, where available.

[Unit Prefix] ic

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 56: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 56/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.

N alphanumeric

250

Page 57: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 57/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Short, High (temperature)

Page 58: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 58/485

4.3.2. SSI for Proteins

For substances that can be classified as proteins, the following data elements shall be specified:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

substance

SUB

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same

Page 59: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 59/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

language are to be considered synonyms.

Substance_id

COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of

Y

Page 60: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 60/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).

Page 61: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 61/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the official name shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed

CV [Status]

Y text 250

Page 62: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 62/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have

Page 63: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 63/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Referenc RS.2.CV The type of the reference CV Y text 250

Page 64: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 64/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_type

source shall be specified based on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_code

COM.SC The substance code section This section describes the specific code(s) within one or

N

Page 65: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 65/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) more available code system(s) that apply to a substance.

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Code_system_change_dat

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format,

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not

Page 66: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 66/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e where applicable. EXAMPLE: 2011-06-01

applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Referenc RS.2.CV The type of the reference CV Y text 250

Page 67: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 67/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_type

source shall be specified based on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of

Y Where no “Version Number” and “Effective Date” have been assigned by an authority

Page 68: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 68/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

the substance. source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about:

Y

Page 69: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 69/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

- substance classification - target - gene from which proteins are derived - substance relationship

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Page 70: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 70/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Substance_classification_c

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled

N alphanumeric

250

Page 71: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 71/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ode vocabulary.

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 72: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 72/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Page 73: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 73/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique

CV [Substance Name]

N Alphanumeric

12

Page 74: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 74/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

“Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of

N alphanumeric

250

Page 75: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 75/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Measure]

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 76: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 76/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Page 77: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 77/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source

RS.3.CV The class of the reference source shall be specified based

CV

Y text 250

Page 78: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 78/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_class on a controlled vocabulary. EXAMPLE: Regulatory submission

[Source Class]

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 79: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 79/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 4000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Page 80: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 80/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:

N/A N text 2500

Page 81: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 81/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Encycl. 3: 429 (1792)

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Page 82: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 82/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.

CV [Source Class]

Y text 250

Page 83: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 83/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Regulatory submission

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance.

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 84: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 84/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, protein/channel, receptor

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N

alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary.

CV [Target type]

N Text 250

Page 85: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 85/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, receptor, membrane

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 86: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 86/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Structure (0..n)

SING.STR The structure section The structure of the substance shall be described, where applicable

N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.

Structural_representation_type

STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI, mol file

CV [Structural Representation Type]

Y Text 250

Structural_representation

STR.2 The structural representation shall be provided. This shall contain only textual

N/A Y Alphanumeric

4000

Page 87: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 87/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.

Structural_representation_attachment

STR.3 A copy of the structural representation shall be provided.

N .jpeg

Stereochemistry

STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.

CV [Stereochemistry]

Y Text 250

Optical_activity

STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)

CV [optical activity]

Y CV 250

Molecula STR.6 The molecular formula shall be N/A N Text 2000

Page 88: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 88/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

r_formula

provided. The molecular formula shall be specified with all the characters in capital letters.

Isotope (0..n)

STR.ISO The isotope section The isotope shall be described in this section, where applicable.

N

Nuclide_id

ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N alphanumeric

12

Nuclide_ ISO.2 The name for the nuclide shall CV Y Text 4000

Page 89: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 89/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

name be provided.

[Substance Name]

Substitution_type

ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown

CV [Substitution Type]

Y Text 250

Protein (0..1)

SING.PRO The protein section The identifying characteristics of the protein shall be specified in this section.

The section is mandatory if Substance_type_cv= Protein

Sequence_type

PRO.1.CV The type of the protein sequence shall be specified based on a controlled vocabulary. EXAMPLE: complete; Partial protein descriptive elements will only be used

CV [Sequence Type]

Y Text 250

Page 90: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 90/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

when a complete or partial amino acid sequence is available or derivable from a nucleic acid sequence.

Number_of_subunits

PRO.2 The number of subunit constituting the protein shall be described. NOTE: If not specified in the reference source, the assumption is that there is 1 subunit.

N/A Y Numeric

4 The value is automatically calculated.

Disulfide_linkage

PRO.3 The position of the disulfide bonds in the protein shall be described. Each disulfidelinkage shall be specified followed by a comma and space (not-repeatable field). The position of the disulfide bonds in the protein shall be described in increasing order of subunit number and position within subunit followed by the abbreviation of the aminoacids involved.

N/A Y Alphanumeric

2500

Page 91: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 91/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: - “Cys1_10-Cys2_16” refers to a disulfide linkage between the residue of cysteine in the position 10 and 16 respectively of the first and second subunit. If disulfide linkage are not present, the value N/A shall be specified.

Comment

PRO.4 Any comment can be provided in this field, if necessary.

N/A N Text 4000

protein_subunit (1..n)

PRO.PSU The protein subunit section This section refers to the description of each constituting the protein. The section is repeatable for each diverse subunit of the protein.

Y

Subunit PSU.1 The numeric value that relates back to the subunit shall be specified in order of decreasing length.

N/A Y Numeric

4

Page 92: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 92/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Sequences of the same length will be ordered by molecular weight. Subunits that have identical sequences will be repeated and have sequential subscripts. EXAMPLE: 1,2,3,..

Sequence

PSU.2 Sequences shall be described using the standard single letter amino acid code. Transcribed proteins will always be described using the translated sequence.

N/A Y Text 4000

Length PSU.3 The number of amino acid residues linked through peptide bonds shall be specified.

N/A Y Alphanumeric

100

N_terminal_modification

PSU.4.CV The modification at the n-terminal of the protein shall be provided based on a controlled vocabulary.

CV [Modification]

Y Text 250

N_terminal_modification_id

PSU.5 The unique identifier assigned to the modification at the N-

CV [Modification]

N Alphanumeric

12 If N_terminal_modification value is not equal to unknown or not applicable, the

Page 93: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 93/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

terminal of the protein based on a Controlled vocabulary.

N_terminal_modification_id field is mandatory.

C_terminal_modification

PSU.6.CV The modification at the c-terminal of the protein shall be provided based on a controlled vocabulary.

CV [Modification]

Y Text 250

C_terminal_modification_id

PSU.7 The unique identifier assigned to the modification at the C-terminal of the protein based on a Controlled vocabulary.

CV [Modification]

N Alphanumeric

12 If C_terminal_modification value is not equal to unknown or not applicable, the C_terminal_modification_id field is mandatory.

Glycosylation (0..n)

PRO.GLY The glycosilation section Details on the glycosilation shall be provided. The section is repeatable to allow the description of each glycosilation present in a protein.

N This section applies if the protein is glycosylated. The value of Glycosylation_type cannot be null. In case of no glycosilation the user must specify the value= Not applicable from the [Glycosylation Type] CV.

Glycosylation_type

GLY.1.CV The type of the glycosilation shall be specified based on a controlled vocabulary. EXAMPLE: human

CV [Glycosylation Type]

Y Text 250

N_glycos GLY.3 The site of n-glycosylation shall N/A N Alpha 4000 If Glycosylation_type = Not

Page 94: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 94/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ylation be described according to the protein sequence. The extent and type of the modification at a given site is not captured. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: asparagine “Asn1_34”

numeric

applicable, this field is not applicable.

O_glycosylation

GLY.4 The site of the o-glycosylation shall be described. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: serine “Ser2_34”

N/A N Alphanumeric

4000 If Glycosylation_type = Not applicable, this field is not applicable.

C_glycosylation

GLY.5 The site of the c-glycosylation shall be described.

N/A N Alphanumeric

4000 If Glycosylation_type = Not applicable, this field is not applicable.

Page 95: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 95/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: tryptophan “Trp2_45”

Modification (0..n)

PRO.MOD The modification section The modification details shall be specified.

N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture This section shall be repeatable to describe each modification occurred on each residue modified.

Modification_type

MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural

CV [Modification Type]

Y Text 250

Page 96: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 96/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Residue_modified

MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;

CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]

Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable

Residue_site

MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space.

N Text 2000

Page 97: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 97/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10

physical_modification (0..n)

MOD.PM The physical modification section

N This section shall only apply if Modification_type= Physical

Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation

CV [Modification]

Y Text 250

Number_of_para

PM.2 The number of parameter that is going to be described as

No N Numeric

4 The value is automatically calculated.

Page 98: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 98/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

meters result of the modification shall be provided.

Parameter (0..n)

PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.

Parameter

PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure

CV [Parameter]

Y Text 250

Amount_type

PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

PARA.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity

N text 250

Page 99: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 99/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Operator]

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_lim AMT.8 The higher limit value of the N Nume 10

Page 100: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 100/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

it_numerator_value

substance shall be specified, where available.

ric

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Page 101: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 101/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

structural_modification (0..n)

MOD.SM The structural modification section

N This section shall apply if Modification_type= Structural This section is repeatable.

Structural_modification_type

SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary

CV [Modification]

Y Text 250

Moiety (0..n)

SM.MOT The moiety section This section describes the

N

Page 102: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 102/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

moiety affected by the modification where applicable.

Moiety_Role

MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate

CV [Role]

Y text 250

Moiety_name

MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.

CV [Substance Name]

Y Text 4000

Moiety_id

MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV.

CV [Substance Name]

N Alphanumeric

12

Page 103: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 103/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Amount_type

MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

MOT.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numer

AMT.4.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanumer

250

Page 104: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 104/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ator_unit_prefix

specified, where available.

[Unit Prefix] ic

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 105: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 105/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.

N alphanumeric

250

Page 106: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 106/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Short, High (temperature)

molecular_fragment (0..n)

SM.MFRAG The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.

N

Role MFRAG.1.CV

The role of the molecular fragment shall be described based on a controlled vocabulary.

CV [Role]

Y Text 250

Molecular_fragment_id

MFRAG.2 The unique identifier for molecular fragment shall be provided.

CV [Substance Name]

N Alphanumeric

12

Molecular_fragment_name

MFRAG.3 The name for molecular fragment shall be specified.

CV [Substance Name]

Y Text 4000

Amount_type

MFRAG.4.CV

The type of the amount of the substance shall be specified

CV

N Text 250

Page 107: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 107/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

using a controlled vocabulary.

[Amount Type]

amount (0..1)

MFRAG.AMT

The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denomin

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of

N alphanumeric

250

Page 108: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 108/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ator _unit

Measure]

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 109: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 109/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

agent_modification (0..n)

MOD.AM The modification agent section. This section described the agent that caused the modification.

N

Page 110: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 110/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Agent_modification_type

AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic

CV [Agent Modification Type]

Y text 250

Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.

CV [Modification]

Y Text 250

Modification_agent

AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

Modification_agent_id

AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the

CV [Substance Name]

N Alphanumeric

12

Page 111: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 111/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

initial submission of the substance this data element is not required.

Modification_process

AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation

CV [Modification Process]

N Text

250

Amount_type

AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

AM.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 112: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 112/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_lim AMT.10.C The prefix of the higher limit CV N alpha 250

Page 113: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 113/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

it_numerator_unit_prefix

V unit of the substance shall be specified, where available.

[Unit Prefix]

numeric

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Page 114: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 114/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular_weight (0..n)

PRO.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid

Molecular_weight_method

MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary. EXAMPLE: sds_page

CV [Method of Measure]

Y text 250

Molecular_weight_type

MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.

CV [Molecular Weight Type]

Y Text 250

Amount_type

MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Amount

MW.AMT The amount section Y

Page 115: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 115/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(1..1) Quantity

Operator AMT.1.CV CV

[Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanumer

250

Page 116: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 116/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

specified, where available.

[Unit Prefix] ic

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 117: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 117/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Property (0..n)

PRO.PROP The property section The characteristics of the property shall be described.

N

Property_type

PROP.1.CV

The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical,

CV [Property Type]

Y Text 250

Page 118: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 118/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

enzymatic, immunological

Property_name

PROP.2.CV

The name of property shall be specified based on a Controlled Vocabulary.

CV [Parameter]

Y Text 250

Substance_id

PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_name

PROP.4 The name of the substance related to a defining property

CV

N Text 4000

Page 119: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 119/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified

[Substance Name]

Amount_type

PROP.5.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (1..1)

PROP.AMT The amount section Y

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 120: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 120/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_prefix

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.11 The higher limit value of the N Nume 10

Page 121: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 121/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_denominator_value

substance shall be specified, where available.

ric

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.

N alphanumeric

250

Page 122: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 122/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Short, High (temperature)

reference_source (1..n)

PRO.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 123: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 123/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

4.3.3. SSI for nucleic acids

For substances, which can be classified as nucleic acid the SSI the following data elements shall be specified:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Page 124: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 124/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

substance

SUB

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

Substance_id

COM.1 The substance identifier shall be described based on a controlled vocabulary.

CV [Substance Name]

N Alphanumeric

12

Page 125: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 125/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Y

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Page 126: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 126/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory.

Page 127: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 127/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have

Page 128: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 128/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

reference_source

SNM.RS The reference source section This section describes the

Y

Page 129: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 129/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

(1..n)

reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described.

N/A N text 2500

Page 130: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 130/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

substance_code (0..n)

COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.

N

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_stat

SC.4.CV The status of the code system shall be specified based on a

CV

Y text 250

Page 131: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 131/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

us controlled vocabulary. EXAMPLE: current, proposed.

[Status]

Code_system_change_date

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is

Yes /No

Y Boolean

Page 132: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 132/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

public or not. Yes or No values apply.

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version

COM.VER The version section

Y Where no “Version Number”

Page 133: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 133/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

(1..n) This section shall provide information on the version of the substance.

and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about: - substance classification

Y

Page 134: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 134/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

- target - gene from which proteins are derived - substance relationship

Comment RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Substance_classification_ty

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary.

CV [Substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the

Page 135: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 135/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

pe NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

[Specified substance Type]

[Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Substance_classification_code

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.

N alphanumeric

250

subtype (1..n)

SCLF.ST The subtype section Y

Page 136: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 136/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 137: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 137/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Page 138: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 138/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Page 139: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 139/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanume

250

Page 140: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 140/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

specified, where available.

[Unit Prefix] ric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Page 141: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 141/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 142: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 142/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 143: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 143/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

substance (protein).

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 4000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Page 144: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 144/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Page 145: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 145/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

Page 146: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 146/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 147: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 147/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_nam

TRG.2 The target gene name shall be specified based on a controlled

CV

Y Text 4000

Page 148: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 148/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

e vocabulary. EXAMPLE: single substance, an enzyme type

[Target Gene]

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane

CV [Target type]

N Text 250

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is

Yes /No

Y Boolean

Page 149: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 149/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

public or not. Yes or No values apply.

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Structure

SING.STR The structure section

N The structure section is mandatory when

Page 150: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 150/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

(0..n) The structure of the substance shall be described, where applicable

Substance_classification_type= chemical, protein, polymer and nucleic acid.

Structural_representation_type

STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI , mol file

CV [Structural Representation Type]

Y Text 250

Structural_representation

STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.

N/A Y Alphanumeric

4000

Structural_representation_attachment

STR.3 A copy of the structural representation shall be provided.

N .jpeg

Page 151: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 151/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Stereochemistry

STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.

CV [Stereochemistry]

Y Text 250

Optical_activity

STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)

CV [optical activity]

Y CV 250

Molecular_formula

STR.6 The molecular formula shall be provided. The molecular formula shall be specified with all the characters in capital letters.

N/A N Text 2000

Isotope (0..n)

STR.ISO The isotope section The isotope shall be described in this section, where applicable.

N

Nuclide_id

ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the

CV [Substance Name]

N alphanumeric

12

Page 152: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 152/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Nuclide_name

ISO.2 The name for the nuclide shall be provided.

CV [Substance Name]

Y Text 4000

Substitution_type

ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown

CV [Substitution Type]

Y Text 250

nucleic_acid (0..1)

SING.NA This section provides a description of the identifying characteristics of a nucleic acid.

The section is mandatory if Substance_type_cv= Nucleic Acid

Sequence_type

NA.1.CV The type of the sequence shall be specified based on a controlled vocabulary.

CV [Sequence Type]

Y Text 250

Page 153: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 153/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

NOTE: complete, partial protein descriptive elements will only be used when a complete or partial amino acid sequence is available or derivable from a nucleic acid sequence.

Number_of_subunits

NA.2 The number of linear sequences of nucleotides linked through phosphodiesteric bonds shall be described. NOTE: If not specified in the reference source, the assumption is that there is 1 subunit.

N/A Y Numeric

4 The value is automatically calculated.

Area_of_hybridisation

NA.3.CV The area of hydbridization shall be described if applicable. The number associated with the subunit followed by the number associated to the residue shall be specified in increasing order. The underscore “_” shall be used as separator as follow: “Subunit_number Residue”. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit

N/A N alphanumeric

250

Page 154: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 154/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Or A1_10, A1_11 Each residue shall be specified followed by a comma and space.

Comment NA.4 Any comment can be provided in this field, if necessary.

N Text 4000

nucleic_acid_subunit (1..n)

NA.NASU The nucleic acid subunit This section describes the nucleic acid subunits.

Y This section is repeatable for each subunit.

Subunit NASU.1 The numeric value that relates back to subunit shall be specified in order of decreasing length. Sequences of the same length will be ordered by molecular weight. Subunits that have identical sequences will be repeated and have sequential subscripts. EXAMPLE: 1,2,3,..

N/A Y Numeric

4

Sequence NASU.2 The nucleotide sequence shall be specified.

N/A Y Alphanumeric

4000

Page 155: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 155/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Length NASU.3 The number of nucleotide residues linked through phosphate esters shall be specified.

N/A N Alphanumeric

100

Five_prime

NASU.4.CV

The nucleotide present at the 5’ terminal shall be specified based on a controlled vocabulary. NOTE: If not specified in the available reference source this value shall be derived from the nucleic acid sequence.

CV: [Nucleotide Bases]

Y Text 250

Three_prime

NASU.5.CV

The nucleotide present at the 3’ terminal shall be specified based on a controlled vocabulary. NOTE: If not specified in the available reference source this value shall be derived from the nucleic acid sequence.

CV [Nucleotide Bases]

Y Text 250

Modification (0..n)

NA.MOD The modification section The modification details shall be specified.

N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture

Page 156: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 156/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

This section shall be repeatable to describe each modification occurred on each residue modified.

Modification_type

MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural

CV [Modification Type]

Y Text 250

Residue_modified

MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;

CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]

Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue

Page 157: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 157/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

modified is= not applicable

Residue_site

MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10

N Text 2000

physical_modification (0..n)

MOD.PM The physical modification section N This section shall only apply if Modification_type= Physical

Role PM.1.CV The role of the physical modification shall be provided based on a controlled

CV [Modification]

Y Text 250

Page 158: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 158/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

vocabulary. EXAMPLE: inactivation, activation

Number_of_parameters

PM.2 The number of parameter that is going to be described as result of the modification shall be provided.

No N Numeric

4 The value is automatically calculated.

Parameter (0..n)

PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.

Parameter

PARA.1.CV

The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure

CV [Parameter]

Y Text 250

Amount_type

PARA.2.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount

PARA.AMT The amount section N

Page 159: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 159/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

(0..1) Quantity

Operator AMT.1.CV CV

[Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.8 The higher limit value of the N Nume 10

Page 160: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 160/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

t_numerator_value

substance shall be specified, where available.

ric

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 161: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 161/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

structural_modification (0..n)

MOD.SM The structural modification section

N This section shall apply if Modification_type= Structural This section is repeatable.

Structural_modification_type

SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary

CV [Modification]

Y Text 250

Moiety (0..n)

SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.

N

Moiety_Role

MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker,

CV [Role]

Y text 250

Page 162: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 162/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

conjugate

Moiety_name

MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.

CV [Substance Name]

Y Text 4000

Moiety_id MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Amount_type

MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Page 163: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 163/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

amount (0..1)

MOT.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 164: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 164/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

prefix

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified,

CV

N alphanumeric

250

Page 165: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 165/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

where available.

[Unit Prefix]

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular_fragment (0..n)

SM.MFRAG

The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.

N

Role MFRAG.1.CV

The role of the molecular fragment shall be described based on a controlled vocabulary.

CV [Role]

Y Text 250

Molecular_fragment_id

MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID”

CV [Substance Name]

N Alphanumeric

12

Page 166: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 166/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

(EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Molecular_fragment_name

MFRAG.3 The name for molecular fragment shall be specified.

CV [Substance Name]

Y Text 4000

Amount_type

MFRAG.4.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

MFRAG.AMT

The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Page 167: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 167/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 168: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 168/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

prefix

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Page 169: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 169/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

agent_modification (0..n)

MOD.AM The modification agent section. This section described the agent that caused the modification.

N

Agent_modification_type

AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic

CV [Agent Modification Type]

Y text 250

Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.

CV [Modification]

Y Text 250

Modification_agent

AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

Modification_agent_id

AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the

CV [Substance Name]

N Alphanumeric

12

Page 170: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 170/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Modification_process

AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation

CV [Modification Process]

N Text

250

Amount_type

AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

AM.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerat

AMT.3.CV The lower limit unit of the substance shall be specified,

CV

N alphanumeric

250

Page 171: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 171/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

or_unit where available.

[Unit of Measure]

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.11 The higher limit value of the N Numer 10

Page 172: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 172/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

t_denominator_value

substance shall be specified, where available.

ic

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Property NA.PROP The property section N

Page 173: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 173/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

(0..n)

The characteristics of the property shall be described.

Property_type

PROP.1.CV

The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological

CV [Property Type]

Y Text 250

Property_name

PROP.2.CV

The name of property shall be specified based on a Controlled Vocabulary.

CV [Parameter]

Y Text 250

Substance_id

PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Page 174: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 174/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Substance_name

PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified

CV [Substance Name]

N Text 4000

Amount_type

PROP.5.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Amount (1..1)

PROP.AMT The amount section Y

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 175: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 175/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV

N alphanum

250

Page 176: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 176/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

denominator _unit

[Unit of Measure]

eric

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular_weight (0..n)

NA.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid

Molecular_weight_method

MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary.

CV [Method of

Y text 250

Page 177: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 177/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

EXAMPLE: sds_page

Measure]

Molecular_weight_type

MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.

CV [Molecular Weight Type]

Y Text 250

Amount_type

MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Amount (1..1)

MWT.AMT The amount section Y

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerat

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where

CV

N alphanum

250

Page 178: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 178/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

or_unit_prefix

available.

[Unit Prefix] eric

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

Page 179: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 179/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

NA.RS The reference source section This section describes the reference source information.

Y

Page 180: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 180/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Page 181: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 181/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference Mandatory

Type Field Length

Business Rules

Page 182: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 182/485

4.3.4. SSI for Polymers

For substances that can be classified as polymers, the following data elements shall be specified:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

substance SUB

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

Substance_id

COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE:

CV [Substance Name]

N Alphanumeric

12

Page 183: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 183/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Y

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Page 184: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 184/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this

Page 185: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 185/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have

Page 186: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 186/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information.

Y

Page 187: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 187/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:

N/A N text 2500

Page 188: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 188/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Encycl. 3: 429 (1792)

substance_code (0..n)

COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.

N

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Page 189: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 189/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Code_system_change_date

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Page 190: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 190/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of the substance.

Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number

Page 191: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 191/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship

Y

Page 192: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 192/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Page 193: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 193/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

Substance_classification_code

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.

N alphanumeric

250

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source

SCLF.RS The reference source section

Y

Page 194: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 194/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(1..n)

This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described.

N/A N text 2500

Page 195: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 195/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described.

CV [Substance Name]

N Alphanumeric

12

Page 196: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 196/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numer

AMT.2 The lower limit value of the substance shall be specified, where

N Numeric

10

Page 197: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 197/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ator_value

available.

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of

N alphanumeric

250

Page 198: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 198/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Measure]

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_nu AMT.17 The non numeric value shall be N alpha 250

Page 199: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 199/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

meric_value

specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

numeric

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 200: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 200/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 4000

Page 201: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 201/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source

RS.3.CV The class of the reference source shall be specified based on a

CV

Y text 250

Page 202: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 202/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_class controlled vocabulary. EXAMPLE: Regulatory submission

[Source Class]

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary.

CV [Substance

N Alphanumeric

12

Page 203: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 203/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Name]

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source

RS.2.CV The type of the reference source shall be specified based on a

CV

Y text 250

Page 204: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 204/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_type controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 205: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 205/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary.

CV [Target

N Text 250

Page 206: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 206/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, receptor, membrane

type]

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Referenc RS.5 The textual description of the N/A N text 2500

Page 207: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 207/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_citation

reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

Structure (0..n)

SING.STR The structure section The structure of the substance shall be described, where applicable

N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.

Structural_representation_type

STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI, mol file

CV [Structural Representation Type]

Y Text 250

Structural_representation

STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information. When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.

N/A Y Alphanumeric

4000

Page 208: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 208/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Structural_representation_attachment

STR.3 A copy of the structural representation shall be provided.

N .jpeg

Stereochemistry

STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.

CV [Stereochemistry]

Y Text 250

Optical_activity

STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)

CV [optical activity]

Y CV 250

Molecular_formula

STR.6 The molecular formula shall be provided. The molecular formula shall be specified with all the characters in capital letters.

N/A N Text 2000

Isotope (0..n)

STR.ISO The isotope section The isotope shall be described in this section, where applicable.

N

Nuclide_id

ISO.1 The identifier for each nuclide shall be provided based on a controlled

CV

N alphanume

12

Page 209: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 209/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

[Substance Name]

ric

Nuclide_name

ISO.2 The name for the nuclide shall be provided.

CV [Substance Name]

Y Text 4000

Substitution_type

ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown

CV [Substitution Type]

Y Text 250

polymer (0..1)

SING.POLY The polymer section The characteristics the uniquely

N The section is mandatory if Substance_type_cv = polymer

Page 210: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 210/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

define a polymer shall be specified in this section.

Polymer_class

POLY.1.CV The class of polymer shall be described based on a controlled vocabulary. EXAMPLE: homopolymer, copolymer

CV [Polymer Class]

Y Text 250

Polymer_geometry

POLY.2.CV The geometry of the polymer shall be described based on a controlled vocabulary. EXAMPLE: linear, branched, cross linked, network, dendritic, star, comb, brush

CV [Geometry]

Y Text 250

Copolymer_sequence_type

POLY.3.CV The type of copolymer of the polymer sequence shall be described based on a controlled vocabulary. EXAMPLE: random, alternating, block, graft, Statistical

CV [Copolymer Sequence Type]

Y Text 250

Comment

POLY.4 Any comment can be provided in this field, if necessary.

N/A N Text 4000

monomer_description

POLY.MDESC The description of the monomer section.

N

Page 211: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 211/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) Number_

of_monomers

MDESC.1 The number of diverse monomers that constitutes the polymer shall be specified.

N/A Y Numeric

4 The value is automatically calculated.

monomer (0..n)

MDESC.MON The monomer section. This section is repeatable for each monomer of the polymer.

Y

Monomer_id

MON.1 The unique identifier assigned to the monomer based on controlled vocabulary.

CV [Substance Name]

N Alphanumeric

12 In the absence of a unique “Substance ID” e.g. for the initial submission of the substance this data element shall not be populated. If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified accordingly.

Monomer_name

MON.2.CV The name of the monomer shall be provided.

CV [Substance Name]

Y Text 4000

Amount_type

MON.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Page 212: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 212/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

amount (0..1)

MON.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limi AMT.7.CV The prefix of the lower limit unit of CV N alpha 250

Page 213: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 213/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_ denominator_unit_prefix

the substance shall be specified, where available.

[Unit Prefix]

numeric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average AMT.14 The average amount or single value N Nume 10

Page 214: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 214/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

of the substance shall be specified.

ric

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

structural_repeat (0..n)

POLY.SR The structural repeat section N This section is mandatory if Number_of_monomers is >1

Number_of_structural_repeat_units

SR.1 The number of diverse repeated units represented in the structure of the polymer shall be specified. The number of time that the monomer is repeated in the polymer. EXAMPLE: PEG 40 is 40

N/A

Y Numeric

4 The value is automatically calculated.

Page 215: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 215/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

structural_repeat_unit (1..n)

SR.SRU Y

Orientation_of_polymerization

SRU.1.CV The orientation of the polymerization shall be described based on a controlled vocabulary. EXAMPLE: head-tail, head-head, random

CV [Orientation]

Y Text 250

Structural_repeat_unit

SRU.2 The letter that relates back to the structure of the unit shall be specified in order of decreasing molecular weight. EXAMPLE: a,b,c,...

N/A N Text 250

Amount_type

SRU.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (1..1)

SRU.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 10

Page 216: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 216/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

250

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

High_limi AMT.9.CV The higher limit unit of the CV N alpha 250

Page 217: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 217/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_numerator_unit

substance shall be specified, where available.

[Unit of Measure]

numeric

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of

N alphanumeric

250

Page 218: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 218/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Measure]

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

degree_polymerization (1..1)

SRU.DOP The degree of the polymerization section.

Y

Degree_of_polymerization

DOP.1.CV The type of the degree of polymerization shall be described.

CV [Degree of Polymerization]

Y Text 250

Amount_type

DOP.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

DOP.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Page 219: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 219/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limi AMT.9.CV The higher limit unit of the CV N alpha 250

Page 220: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 220/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_numerator_unit

substance shall be specified, where available.

[Unit of Measure]

numeric

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of

N alphanumeric

250

Page 221: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 221/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Measure]

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular_weight (0..n)

POLY.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid

Molecular_weight_method

MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary. EXAMPLE: sds_page

CV [Method of Measure]

Y text 250

Molecular_weight_type

MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.

CV [Molecular Weight Type]

Y Text 250

Amount_type

MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Amount (1..1)

MWT.AMT The amount section Y

Page 222: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 222/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 223: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 223/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where

CV

N alphanume

250

Page 224: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 224/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

available.

[Unit Prefix]

ric

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Property (0..n)

POLY.PROP The property section The characteristics of the property shall be described.

N

Property_type

PROP.1.CV The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological

CV [Property Type]

Y Text 250

Property_name

PROP.2.CV The name of property shall be specified based on a Controlled Vocabulary.

CV [Parameter]

Y Text 250

Substance_id

PROP.3 The identifier of the substance related to a defining property shall

CV

N Alphanume

12

Page 225: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 225/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

[Substance Name]

ric

Substance_name

PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified

CV [Substance Name]

N Text 4000

Amount_type

PROP.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (1..1)

PROP.AMT The amount section Y

Page 226: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 226/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 227: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 227/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where

CV

N alphanume

250

Page 228: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 228/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

available.

[Unit Prefix]

ric

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Modification (0..n)

POLY.MOD The modification section The modification details shall be specified.

N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture This section shall be repeatable to describe each modification occurred on each residue modified.

Modification_type

MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural

CV [Modification Type]

Y Text 250

Page 229: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 229/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Residue_modified

MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;

CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]

Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable

Residue_site

MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified

N Text 2000

Page 230: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 230/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10

physical_modification (0..n)

MOD.PM The physical modification section N This section shall only apply if Modification_type= Physical

Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation

CV [Modification]

Y Text 250

Number_of_parameters

PM.2 The number of parameter that is going to be described as result of the modification shall be provided.

No N Numeric

4 The value is automatically calculated.

Parameter (0..n)

PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the

Page 231: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 231/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

‘number_of_parameters’ field.

Parameter

PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure

CV [Parameter]

Y Text 250

Amount_type

PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

PARA.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numer

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified,

CV

N alphanumer

250

Page 232: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 232/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ator_unit_prefix

where available.

[Unit Prefix]

ic

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_val

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

Page 233: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 233/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ue

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

structural_modification

MOD.SM The structural modification section N This section shall apply if Modification_type= Structural

Page 234: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 234/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n)

This section is repeatable.

Structural_modification_type

SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary

CV [Modification]

Y Text 250

Moiety (0..n)

SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.

N

Moiety_Role

MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate

CV [Role]

Y text 250

Moiety_name

MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.

CV [Substance Name]

Y Text 4000

Moiety_id

MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE:

CV [Substance Name]

N Alphanumeric

12

Page 235: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 235/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Amount_type

MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

MOT.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 236: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 236/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.11 The higher limit value of the N Nume 10

Page 237: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 237/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_denominator_value

substance shall be specified, where available.

ric

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular_ SM.MFRAG The molecular fragment section. N

Page 238: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 238/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

fragment (0..n)

This section describes the molecular fragment affected by the modification where applicable.

Role MFRAG.1.CV The role of the molecular fragment shall be described based on a controlled vocabulary.

CV [Role]

Y Text 250

Molecular_fragment_id

MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Molecular_fragment_name

MFRAG.3 The name for molecular fragment shall be specified.

CV [Substance Name]

Y Text 4000

Amount_type

MFRAG.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount

N Text 250

Page 239: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 239/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Type]

amount (0..1)

MFRAG.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 240: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 240/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 241: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 241/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

agent_modification (0..n)

MOD.AM The modification agent section. This section described the agent that caused the modification.

N

Agent_modification_type

AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic

CV [Agent Modification Type]

Y text 250

Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.

CV [Modificatio

Y Text 250

Page 242: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 242/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

n]

Modification_agent

AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

Modification_agent_id

AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Modification_process

AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation

CV [Modification Process]

N Text

250

Amount_type

AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Page 243: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 243/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

amount (0..1)

AM.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified,

CV

N alphanume

250

Page 244: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 244/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

where available.

[Unit Prefix]

ric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Page 245: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 245/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

source_material (0..n)

POLY.SRCM The source material section The source material shall be specified in this section.

N

Source_material_class

SRCM.1.CV The classification of the source material shall be specified based on controlled vocabulary. EXAMPLE: organic, inorganic

CV [Source Material Cass]

Y text 250 The source material class values allow the display of different Source_material_type value as specified below.

Source_material_type

SRCM.2.CV The type of the source material shall be specified based on controlled vocabulary. For vaccines this section refers to

CV organism type]

Y text 250 If Source material class= inorganic, the [Inorganic Material Type] CV applies If Source material class =

Page 246: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 246/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

the class of infectious agent. EXAMPLE: bacterium, human, mammal, fungus, virus, plant

Or [Inorganic Material Type]

organic, CV organism type] applies

Source_material_state

SRCM.3.CV The state of the source material shall be specified based on controlled vocabulary. EXAMPLE: live, activated, inactivated, attenuated, conjugated, live (attenuated).

CV [Source material state]

Y text 250

Organism_id

SRCM.4 The unique identifier associated with the source material parent organism shall be specified.

CV [Organism Name]

N Alphanumeric

12

Organism_name

SRCM.5 The organism accepted Latin name shall be provided based on the binomial Latin nomenclature. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

CV [Organism Name]

Y text 4000

Developmental_stage

SRCM.6.CV The developmental stage shall be defined based on a controlled vocabulary. EXAMPLE: foetus, infant, juvenile, adult, senescent, leafing, pre-flowering, flowering, fruiting

CV [Developmental Stage]

N text 250

Page 247: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 247/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Part (0..n)

SRCM.PT The part section is required to be provided where applicable.

N

Part PT.1.CV The portion of an organism with a definable anatomical location shall be described based on a controlled vocabulary.

CV [Plant Part] Or [Organism Part]

Y Text 250 If Source_material_type= human or mammalian the [organism part] CV applies; If Source_material_type= plant, [Plant Part] CV applies

Part_location

PT.2.CV The anatomical location shall be specified based on a controlled vocabulary. EXAMPLE: Stomach, shoulder

CV [Location]

Y Text 250 Applicable only if Source_material_type= human or mammalian

Fraction (0..n)

SRCM.FRCT The fraction section. Fraction of the part if applicable

N

Material_type

FRCT.1.CV The material type shall be specified based on a controlled vocabulary. EXAMPLE: cell, polysaccharide

CV [Material Type]

Y Text 250

Fraction FRCT.2.CV The fraction shall be specified based on a controlled vocabulary. The fractions of fractions are

CV [Fraction]

N Text 250

Page 248: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 248/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

allowed.

organism (0..n)

SRCM.ORG The organism section The organism shall be defined based on specific elements defined in this section. This section describes the organism which the substance derived from. For vaccines, the parent organism shall be specified based on these section elements. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

N

Kingdom ORG.1.CV The kingdom of an organism shall be specified based on a controlled vocabulary.

CV [Kingdom]

N Text 250

Phylum ORG.2.CV The phylum of an organism shall be specified based on a controlled vocabulary.

CV [Phylum]

N Text 250

Class ORG.3.CV The class of an organism shall be specified based on a controlled vocabulary.

CV [Class]

N Text 250

Page 249: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 249/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Mammalia, maxillopoda, Sauropsida

Order ORG.4.CV The order of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Primate

CV [Order]

N Text 250

Family ORG.5.CV The family of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Homidae

CV [Family]

N Text 250

Genus ORG.6.CV The genus of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the genus of the plant/animal; it is present in names for genera, species and infraspecies EXAMPLE: Tanacetum

CV [Genus]

Y Text 250

Species ORG.7.CV The species of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the species of the plant/animal; it is

CV [Species]

Y Text 250

Page 250: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 250/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

present in names for species and infraspecies EXAMPLE: Parthenium

Species_parenthetical_author

ORG.8 The parenthetical author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank). EXAMPLE: (L.)

N/A N Text 2000

Species_parenthetical_author_year

ORG.9 The parenthetical author year of an organism species an organism shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank). For vaccines names, it refers to the year of isolation. EXAMPLE: 2010/2011

N/A N alphanumeric

10

Species_primary_author

ORG.10 The primary author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank) EXAMPLE: Sch.Bip

N/A N Text 2000

Page 251: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 251/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Species_primary_author_year

ORG.11 The primary author year of an organism species shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank)

N/A N alphanumeric

10

Hybrid_species_maternal_organism_id

ORG.12 The identifier of the maternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.

CV [Species]

N Alphanumeric

12

Hybrid_species_paternal_organism_id

ORG.13 The identifier of the paternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.

CV [Species]

N Alphanumeric

12

Hybrid_type

ORG.14 The hybrid type of an organism shall be defined.

Yes/No

N Boolean

Infraspecfic_type

ORG.15.CV The infraspecific type of an organism shall be specified based on a controlled vocabulary.

CV [Infraspecific Type]

N Text 250

Infraspec_descripti

ORG.16 The infraspecific description of an organism shall be specified based on a controlled vocabulary. For Influenza Vaccine, the infraspecifc description shall contain

N/A

N Text 4000

Page 252: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 252/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

the syntax of the antigen in line with the WHO convention. EXAMPLE: A/BRISBANE/59/2007(H1N1)

Infraspecific_parenthetical_author

ORG.17 The infraspecific parenthetical author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any rank)

N/A N Text 2000

Infraspecific_parenthetical_author_year

ORG.18 The infraspecific parenthetical author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any rank)

N/A N alphanumeric

10

Infraspecific_primary_author

ORG.19 The infraspecific primary author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any infraspecific rank)

N/A N Text 2000

Infraspecific_primary_auth

ORG.20 The infraspecific primary author year of an organism shall be specified.

N/A N alphanumeric

10

Page 253: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 253/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

or_year Refers to the year in which the first author published the infraspecific plant/animal name (of any infraspecific rank)

reference_source (1..n)

POLY.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 254: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 254/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Page 255: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 255/485

Page 256: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 256/485

4.3.5. SSI for Structurally Diverse Substances

For substances that can be classified as structurally diverse, the following data elements shall be specified:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

substance

SUB

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered

Page 257: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 257/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

synonyms.

Substance_id

COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance.

Y

Page 258: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 258/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).

Page 259: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 259/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Page 260: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 260/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have

Page 261: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 261/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Referenc RS.2.CV The type of the reference CV Y text 250

Page 262: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 262/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_type

source shall be specified based on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_code

COM.SC The substance code section This section describes the specific code(s) within one or

N

Page 263: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 263/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) more available code system(s) that apply to a substance.

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Code_system_change_da

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format,

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not

Page 264: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 264/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

te where applicable. EXAMPLE: 2011-06-01

applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Referenc RS.2.CV The type of the reference CV Y text 250

Page 265: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 265/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_type

source shall be specified based on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of

Y Where no “Version Number” and “Effective Date” have been assigned by an authority

Page 266: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 266/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

the substance. source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about:

Y

Page 267: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 267/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

- substance classification - target - gene from which proteins are derived - substance relationship

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Page 268: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 268/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Substance_classification_c

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled

N alphanumeric

250

Page 269: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 269/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ode vocabulary.

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 270: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 270/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Page 271: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 271/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique

CV [Substance Name]

N Alphanumeric

12

Page 272: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 272/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

“Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of

N alphanumeric

250

Page 273: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 273/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Measure]

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 274: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 274/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Page 275: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 275/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source

RS.3.CV The class of the reference source shall be specified based

CV

Y text 250

Page 276: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 276/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_class on a controlled vocabulary. EXAMPLE: Regulatory submission

[Source Class]

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 277: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 277/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 2000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Page 278: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 278/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:

N/A N text 2500

Page 279: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 279/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Encycl. 3: 429 (1792)

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Page 280: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 280/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.

CV [Source Class]

Y text 250

Page 281: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 281/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Regulatory submission

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance.

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 282: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 282/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, protein/channel, receptor

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary.

CV [Target type]

N Text 250

Page 283: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 283/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, receptor, membrane

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Referenc RS.4 The code or number referring N/A N alpha 12

Page 284: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 284/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_id

to the reference source shall be specified.

numeric

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Structure (0..n)

SING.STR The structure section The structure of the substance shall be described, where applicable

N The structure section is mandatory when Substance_classification_type= chemical, protein, polymer and nucleic acid.

Structural_representation_type

STR.1.CV The type of the structural representation shall be described based on a controlled vocabulary. EXAMPLE: InChI, mol file

CV [Structural Representation Type]

Y Text 250

Structural_representation

STR.2 The structural representation shall be provided. This shall contain only textual and not graphical information.

N/A Y Alphanumeric

4000

Page 285: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 285/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

When we enter more than one structural representation, the whole section is repeated (includes stereochemistry, optical activity etc) E.g. for an InChI code this field is populated with the InChI representation.

Structural_representation_attachment

STR.3 A copy of the structural representation shall be provided.

N .jpeg

Stereochemistry

STR.4.CV The stereochemistry of the substance shall be described based on a controlled vocabulary.

CV [Stereochemistry]

Y Text 250

Optical_activity

STR.5.CV The optical activity shall be described based on a controlled vocabulary. EXAMPLE: (+), (-), (+/-)

CV [optical activity]

Y CV 250

Molecular_formul

STR.6 The molecular formula shall be provided.

N/A N Text 2000

Page 286: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 286/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

a The molecular formula shall be specified with all the characters in capital letters.

Isotope (0..n)

STR.ISO The isotope section The isotope shall be described in this section, where applicable.

N

Nuclide_id

ISO.1 The identifier for each nuclide shall be provided based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N alphanumeric

12

Nuclide_name

ISO.2 The name for the nuclide shall be provided.

CV

Y Text 4000

Page 287: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 287/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

[Substance Name]

Substitution_type

ISO.3.CV The type of substitution shall be described using a controlled vocabulary. Substitution refers to the relationship between the nuclide and the rest of the substance EXAMPLE: specific; non-specific; unknown

CV [Substitution Type]

Y Text 250

structurally_Diverse_Substance (0..1)

SING.SD The structurally diverse substance section The identifying characteristics of the structurally diverse substances shall be specified.

Comment

SD.1 Any comment can be provided in this field, if necessary.

Modification (0..n)

SD.MOD The modification section The modification details shall be specified.

N This section apply to: -Nucleic Acid -Protein -Polymer -Structurally Diverse Substances

Page 288: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 288/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

-Mixture This section shall be repeatable to describe each modification occurred on each residue modified.

Modification_type

MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural

CV [Modification Type]

Y Text 250

Residue_modified

MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;

CV [Nucleotide Bases] OR [Aminoacid] OR [Substance Name]

Y Text 4000 If Substance_classification_type= protein, the CV [Aminoacid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies; If Substance_classification_type= polymer, the CV [Substance Name] applies.

Page 289: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 289/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable

Residue_site

MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or A1_10

N Text 2000

physical_ MOD.PM The physical modification N This section shall only apply if

Page 290: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 290/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

modification (0..n)

section Modification_type= Physical

Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation

CV [Modification]

Y Text 250

Number_of_parameters

PM.2 The number of parameter that is going to be described as result of the modification shall be provided.

No N Numeric

4 The value is automatically calculated.

Parameter (0..n)

PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.

Parameter

PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature,

CV [Parameter]

Y Text 250

Page 291: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 291/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

pressure

Amount_type

PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

PARA.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denomi

AMT.5 The lower limit value of the substance shall be specified,

N Numeric

10

Page 292: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 292/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

nator_value

where available.

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

Page 293: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 293/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Page 294: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 294/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

structural_modification (0..n)

MOD.SM The structural modification section

N This section shall apply if Modification_type= Structural This section is repeatable.

Structural_modification_type

SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary

CV [Modification]

Y Text 250

Moiety (0..n)

SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.

N

Moiety_Role

MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate

CV [Role]

Y text 250

Moiety_name

MOT.2 The name of the moiety shall be provided. If the substance name is not present in the Controlled Vocabulary, the moiety name

CV [Substance Name]

Y Text 4000

Page 295: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 295/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

shall be described as a free text.

Moiety_id

MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Amount_type

MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

MOT.AMT The amount section N

Quantity AMT.1.CV CV N text 250

Page 296: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 296/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Operator [Quantity Operator]

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 297: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 297/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Page 298: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 298/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular_fragment (0..n)

SM.MFRAG The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.

N

Role MFRAG.1.CV

The role of the molecular fragment shall be described based on a controlled vocabulary.

CV [Role]

Y Text 250

Page 299: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 299/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Molecular_fragment_id

MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Molecular_fragment_name

MFRAG.3 The name for molecular fragment shall be specified.

CV [Substance Name]

Y Text 4000

Amount_type

MFRAG.4.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount

MFRAG.AMT

The amount section N

Page 300: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 300/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..1)

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanume

250

Page 301: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 301/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

specified, where available.

[Unit Prefix] ric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 302: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 302/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

agent_modification (0..n)

MOD.AM The modification agent section. This section described the agent that caused the modification.

N

Agent_modification_type

AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary.

CV [Agent Modification

Y text 250

Page 303: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 303/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: chemical, enzymatic

Type]

Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.

CV [Modification]

Y Text 250

Modification_agent

AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

Modification_agent_id

AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Page 304: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 304/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Modification_process

AM.5.CV The modification process shall be specified based on a controlled vocabulary. EXAMPLE: UV irradiation

CV [Modification Process]

N Text

250

Amount_type

AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

AM.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 305: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 305/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_prefix

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.11 The higher limit value of the N Nume 10

Page 306: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 306/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_denominator_value

substance shall be specified, where available.

ric

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.

N alphanumeric

250

Page 307: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 307/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Short, High (temperature)

Property (0..n)

SD.PROP The property section The characteristics of the property shall be described.

N

Property_type

PROP.1.CV

The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological

CV [Property Type]

Y Text 250

Property_name

PROP.2.CV

The name of property shall be specified based on a Controlled Vocabulary.

CV [Parameter]

Y Text 250

Substance_id

PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary. EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID”

CV [Substance Name]

N Alphanumeric

12

Page 308: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 308/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified

CV [Substance Name]

N Text 4000

Amount_type

PROP.5.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (1..1)

PROP.AMT The amount section Y

Quantity Operator

AMT.1.CV CV

N text 250

Page 309: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 309/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

[Quantity Operator]

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 310: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 310/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Page 311: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 311/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

source_material (0..n)

SD.SRCM The source material section The source material shall be specified in this section.

N

Source_material_class

SRCM.1.CV

The classification of the source material shall be specified based on controlled vocabulary. EXAMPLE: organic, inorganic

CV [Source Material Cass]

Y text 250 The source material class values allow the display of different Source_material_type value as specified below.

Source_material

SRCM.2.CV

The type of the source material shall be specified based on

CV

Y text 250 If Source material class= inorganic, the [Inorganic

Page 312: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 312/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_type controlled vocabulary. For vaccines this section refers to the class of infectious agent. EXAMPLE: bacterium, human, mammal, fungus, virus, plant

organism type] Or [Inorganic Material Type]

Material Type] CV applies If Source material class = organic, CV organism type] applies

Source_material_state

SRCM.3.CV

The state of the source material shall be specified based on controlled vocabulary. EXAMPLE: live, activated, inactivated, attenuated, conjugated, live (attenuated).

CV [Source material state]

Y text 250

Organism _id

SRCM.4 The unique identifier associated with the source material parent organism shall be specified.

CV [Organism Name]

N Alphanumeric

12

Organism_name

SRCM.5 The organism accepted Latin name shall be provided based on the binomial Latin nomenclature. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

CV [Organism Name]

Y text 4000

Page 313: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 313/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Developmental_stage

SRCM.6.CV

The developmental stage shall be defined based on a controlled vocabulary. EXAMPLE: foetus, infant, juvenile, adult, senescent, leafing, pre-flowering, flowering, fruiting

CV [Developmental Stage]

N text 250

Part (0..n)

SRCM.PT The part section is required to be provided where applicable.

N

Part PT.1.CV The portion of an organism with a definable anatomical location shall be described based on a controlled vocabulary.

CV [Plant Part] Or [Organism Part]

Y Text 250 If Source_material_type= human or mammalian the [organism part] CV applies; If Source_material_type= plant, [Plant Part] CV applies

Part_location

PT.2.CV The anatomical location shall be specified based on a controlled vocabulary. EXAMPLE: Stomach, shoulder

CV [Location]

Y Text 250 Applicable only if Source_material_type= human or mammalian

Fraction

SRCM.FRCT

The fraction section.

N

Page 314: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 314/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) Fraction of the part if applicable

Material_type

FRCT.1.CV The material type shall be specified based on a controlled vocabulary. EXAMPLE: cell, polysaccharide

CV [Material Type]

Y Text 250

Fraction FRCT.2.CV The fraction shall be specified based on a controlled vocabulary. The fractions of fractions are allowed.

CV [Fraction]

N Text 250

organism (0..n)

SRCM.ORG

The organism section The organism shall be defined based on specific elements defined in this section. This section describes the organism which the substance derived from. For vaccines, the parent organism shall be specified based on these section elements. The latest version of the

N

Page 315: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 315/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Kingdom ORG.1.CV The kingdom of an organism shall be specified based on a controlled vocabulary.

CV [Kingdom]

N Text 250

Phylum ORG.2.CV The phylum of an organism shall be specified based on a controlled vocabulary.

CV [Phylum]

N Text 250

Class ORG.3.CV The class of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Mammalia, maxillopoda, Sauropsida

CV [Class]

N Text 250

Order ORG.4.CV The order of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Primate

CV [Order]

N Text 250

Family ORG.5.CV The family of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Homidae

CV [Family]

N Text 250

Page 316: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 316/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Genus ORG.6.CV The genus of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the genus of the plant/animal; it is present in names for genera, species and infraspecies EXAMPLE: Tanacetum

CV [Genus]

Y Text 250

Species ORG.7.CV The species of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the species of the plant/animal; it is present in names for species and infraspecies EXAMPLE: Parthenium

CV [Species]

Y Text 250

Species_parenthetical_author

ORG.8 The parenthetical author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank).

N/A N Text 2000

Page 317: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 317/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: (L.)

Species_parenthetical_author_year

ORG.9 The parenthetical author year of an organism species an organism shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank). For vaccines names, it refers to the year of isolation. EXAMPLE: 2010/2011

N/A N alphanumeric

10

Species_primary_author

ORG.10 The primary author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank) EXAMPLE: Sch.Bip

N/A N Text 2000

Species_primary_author_year

ORG.11 The primary author year of an organism species shall be specified.

N/A N alphanumeric

10

Page 318: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 318/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Refers to the year in which the first author published the plant/animal name (of any rank)

Hybrid_species_maternal_organism_id

ORG.12 The identifier of the maternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.

CV [Species]

N Alphanumeric

12

Hybrid_species_paternal_organism_id

ORG.13 The identifier of the paternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.

CV [Species]

N Alphanumeric

12

Hybrid_type

ORG.14 The hybrid type of an organism shall be defined.

Yes/No

N Boolean

Infraspecfic_type

ORG.15.CV

The infraspecific type of an organism shall be specified based on a controlled vocabulary.

CV [Infraspecific Type]

N Text 250

Infraspec_descripti

ORG.16 The infraspecific description of an organism shall be specified based on a controlled vocabulary.

N/A

N Text 4000

Page 319: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 319/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For Influenza Vaccine, the infraspecifc description shall contain the syntax of the antigen in line with the WHO convention. EXAMPLE: A/BRISBANE/59/2007(H1N1)

Infraspecific_parenthetical_author

ORG.17 The infraspecific parenthetical author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any rank)

N/A N Text 2000

Infraspecific_parenthetical_author_year

ORG.18 The infraspecific parenthetical author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any rank)

N/A N alphanumeric

10

Infraspecific_prim

ORG.19 The infraspecific primary author of an organism shall be

N/A N Text 2000

Page 320: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 320/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ary_author

specified. Refers to the first author, who published the infraspecific plant/animal name (of any infraspecific rank)

Infraspecific_primary_author_year

ORG.20 The infraspecific primary author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any infraspecific rank)

N/A N alphanumeric

10

glycosylation (0..n)

SD.GLY The glycosilation section Details on the glycosilation shall be provided. The section is repeatable to allow the description of each glycosilation present in a protein.

N This section applies if the protein is glycosylated. The value of Glycosylation_type cannot be null. In case of no glycosilation the user must specify the value= Not applicable from the [Glycosylation Type] CV.

Glycosylation_type

GLY.1.CV The type of the glycosilation shall be specified based on a controlled vocabulary.

CV [Glycosylation

Y Text 250

Page 321: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 321/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: human

Type]

N_glycosylation

GLY.2 The site of n-glycosylation shall be described according to the protein sequence. The extent and type of the modification at a given site is not captured. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: asparagine “Asn1_34”

N/A N Alphanumeric

4000 If Glycosylation_type = Not applicable, this field is not applicable.

O_glycosylation

GLY.3 The site of the o-glycosylation shall be described. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid”

N/A N Alphanumeric

4000 If Glycosylation_type = Not applicable, this field is not applicable.

Page 322: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 322/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: serine “Ser2_34”

C_glycosylation

GLY.4 The site of the c-glycosylation shall be described. The convention to be used is as follow: “3 Aminoacid code letter+subunit number”_”position of aminoacid” EXAMPLE: tryptophan “Trp2_45”

N/A N Alphanumeric

4000 If Glycosylation_type = Not applicable, this field is not applicable.

molecular_weight (0..n)

SD.MWT The molecular weight section N The section is mandatory if Substance_classification_type= protein, polymer or nucleic acid

Molecular_weight_method

MWT.1.CV The method used to measure the molecular weight shall be specified based on a controlled vocabulary. EXAMPLE: sds_page

CV [Method of Measure]

Y text 250

Molecular_weight_type

MWT.2.CV The type of the molecular weight shall be specified based on a controlled vocabulary.

CV [Molecular Weight Type]

Y Text 250

Page 323: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 323/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Amount_type

MWT.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (1..1)

MW.AMT The amount section Y

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Page 324: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 324/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denomin

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of

N alphanumeric

250

Page 325: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 325/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ator _unit

Measure]

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source

SD.RS The reference source section This section describes the

Y

Page 326: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 326/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(1..n) reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source

RS.5 The textual description of the reference source within the

N/A N text 2500

Page 327: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 327/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_citation literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

Page 328: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 328/485

4.3.6. SSI for Mixtures

For substances that can be classified as a mixture substance, the following data elements shall be specified:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

substance

SUB

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered

Page 329: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 329/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

synonyms.

Substance_id

COM.1 The substance identifier shall be described based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance.

Y

Page 330: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 330/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).

Page 331: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 331/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Page 332: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 332/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have

Page 333: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 333/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Referenc RS.2.CV The type of the reference CV Y text 250

Page 334: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 334/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_type

source shall be specified based on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_code

COM.SC The substance code section This section describes the specific code(s) within one or

N

Page 335: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 335/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) more available code system(s) that apply to a substance.

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Code_system_change_dat

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format,

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not

Page 336: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 336/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e where applicable. EXAMPLE: 2011-06-01

applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Referenc RS.2.CV The type of the reference CV Y text 250

Page 337: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 337/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_type

source shall be specified based on a controlled vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of

Y Where no “Version Number” and “Effective Date” have been assigned by an authority source,

Page 338: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 338/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

the substance. the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about:

Y

Page 339: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 339/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

- substance classification - target - gene from which proteins are derived - substance relationship

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Page 340: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 340/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Substance_classification_c

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled

N alphanumeric

250

Page 341: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 341/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ode vocabulary.

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 342: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 342/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Page 343: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 343/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique

CV [Substance Name]

N Alphanumeric

12

Page 344: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 344/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

“Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of

N alphanumeric

250

Page 345: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 345/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Measure]

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Page 346: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 346/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Page 347: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 347/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source

RS.3.CV The class of the reference source shall be specified based

CV

Y text 250

Page 348: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 348/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_class on a controlled vocabulary. EXAMPLE: Regulatory submission

[Source Class]

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 349: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 349/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 2000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Page 350: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 350/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference:

N/A N text 2500

Page 351: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 351/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Encycl. 3: 429 (1792)

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Page 352: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 352/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary.

CV [Source Class]

Y text 250

Page 353: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 353/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Regulatory submission

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance.

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 354: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 354/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, protein/channel, receptor

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary.

CV [Target type]

N Text 250

Page 355: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 355/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, receptor, membrane

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Referenc RS.4 The code or number referring to N/A N alpha 12

Page 356: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 356/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

e_source_id

the reference source shall be specified.

numeric

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

mixture_substance (0..1)

EXT.MIXT The mixture substance section The identifying characteristics for a mixture substance shall be described.

The section is mandatory if Substance_type_cv = Mixture

Mixture_type

MIXT.1.CV The type of the mixture shall be specified based on a controlled vocabulary. EXAMPLE: one of, all of, any of

CV [Mixture Type]

Y Text 250

source_material (0..n)

MIXT.SRCM

The source material section The source material shall be specified in this section.

N

Source_ SRCM.1.C The classification of the source CV Y text 250

Page 357: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 357/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

material_class

V material shall be specified based on controlled vocabulary. EXAMPLE: organic, inorganic

[Source Material Cass]

The source material class values allow the display of different Source_material_type value as specified below.

Source_material_type

SRCM.2.CV

The type of the source material shall be specified based on controlled vocabulary. For vaccines this section refers to the class of infectious agent. EXAMPLE: bacterium, human, mammal, fungus, virus, plant

CV organism type] Or [Inorganic Material Type]

Y text 250 If Source material class= inorganic, the [Inorganic Material Type] CV applies If Source material class = organic, CV organism type] applies

Source_material_state

SRCM.3.CV

The state of the source material shall be specified based on controlled vocabulary. EXAMPLE: live, activated, inactivated, attenuated, conjugated, live (attenuated).

CV [Source material state]

Y text 250

Organism _id

SRCM.4 The unique identifier associated with the source material parent organism shall be specified.

CV [Organism Name]

N Alphanumeric

12

Organism_name

SRCM.5 The organism accepted Latin name shall be provided based on the binomial Latin

CV [Organism

Y text 4000

Page 358: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 358/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

nomenclature. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Name]

Developmental_stage

SRCM.6.CV

The developmental stage shall be defined based on a controlled vocabulary. EXAMPLE: foetus, infant, juvenile, adult, senescent, leafing, pre-flowering, flowering, fruiting

CV [Developmental Stage]

N text 250

Part (0..n)

SRCM.PT The part section is required to be provided where applicable.

N

Part PT.1.CV The portion of an organism with a definable anatomical location shall be described based on a controlled vocabulary.

CV [Plant Part] Or [Organism Part]

Y Text 250 If Source_material_type= human or mammalian the [organism part] CV applies; If Source_material_type= plant, [Plant Part] CV applies

Part_loca PT.2.CV The anatomical location shall be CV Y Text 250 Applicable only if

Page 359: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 359/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

tion specified based on a controlled vocabulary. EXAMPLE: Stomach, shoulder

[Location]

Source_material_type= human or mammalian

Fraction (0..n)

SRCM.FRCT

The fraction section. Fraction of the part if applicable

N

Material_type

FRCT.1.CV The material type shall be specified based on a controlled vocabulary. EXAMPLE: cell, polysaccharide

CV [Material Type]

Y Text 250

Fraction FRCT.2.CV The fraction shall be specified based on a controlled vocabulary. The fractions of fractions are allowed.

CV [Fraction]

N Text 250

organism (0..n)

SRCM.ORG

The organism section The organism shall be defined based on specific elements defined in this section. This section describes the organism which the substance

N

Page 360: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 360/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

derived from. For vaccines, the parent organism shall be specified based on these section elements. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Kingdom ORG.1.CV The kingdom of an organism shall be specified based on a controlled vocabulary.

CV [Kingdom]

N Text 250

Phylum ORG.2.CV The phylum of an organism shall be specified based on a controlled vocabulary.

CV [Phylum]

N Text 250

Class ORG.3.CV The class of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Mammalia, maxillopoda, Sauropsida

CV [Class]

N Text 250

Order ORG.4.CV The order of an organism shall be specified based on a controlled vocabulary.

CV [Order]

N Text 250

Page 361: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 361/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Primate

Family ORG.5.CV The family of an organism shall be specified based on a controlled vocabulary. EXAMPLE: Homidae

CV [Family]

N Text 250

Genus ORG.6.CV The genus of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the genus of the plant/animal; it is present in names for genera, species and infraspecies EXAMPLE: Tanacetum

CV [Genus]

Y Text 250

Species ORG.7.CV The species of an organism shall be specified based on a controlled vocabulary. Refers to the Latin epithet of the species of the plant/animal; it is present in names for species and infraspecies

CV [Species]

Y Text 250

Page 362: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 362/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Parthenium

Species_parenthetical_author

ORG.8 The parenthetical author of an organism species shall be specified. Refers to the first author, who published the plant/animal name (of any rank). EXAMPLE: (L.)

N/A N Text 2000

Species_parenthetical_author_year

ORG.9 The parenthetical author year of an organism species an organism shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank). For vaccines names, it refers to the year of isolation. EXAMPLE: 2010/2011

N/A N alphanumeric

10

Species_primary_author

ORG.10 The primary author of an organism species shall be specified. Refers to the first author, who

N/A N Text 2000

Page 363: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 363/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

published the plant/animal name (of any rank) EXAMPLE: Sch.Bip

Species_primary_author_year

ORG.11 The primary author year of an organism species shall be specified. Refers to the year in which the first author published the plant/animal name (of any rank)

N/A N alphanumeric

10

Hybrid_species_maternal_organism_id

ORG.12 The identifier of the maternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.

CV [Species]

Y Alphanumeric

12

Hybrid_species_paternal_organism_id

ORG.13 The identifier of the paternal species constituting the hybrid organism shall be specified based on a controlled vocabulary.

CV [Species]

N Alphanumeric

12

Hybrid_type

ORG.14 The hybrid type of an organism shall be defined. EXAMPLE: yes/no

Yes/No

N Boolean

Page 364: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 364/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Infraspeific_type

ORG.15.CV

The infraspecific type of an organism shall be specified based on a controlled vocabulary.

CV [Infraspecific Type]

N Text 250

Infraspec_descript

ORG.16 The infraspecific description of an organism shall be specified based on a controlled vocabulary. For Influenza Vaccine, the infraspecifc description shall contain the syntax of the antigen in line with the WHO convention. EXAMPLE: A/BRISBANE/59/2007(H1N1)

N/A

N Text 4000

Infraspecific_parenthetical_author

ORG.17 The infraspecific parenthetical author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any rank)

N/A N Text 2000

Page 365: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 365/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Infraspecific_parenthetical_author_year

ORG.18 The infraspecific parenthetical author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any rank)

N/A N alphanumeric

10

Infraspecific_primary_author

ORG.19 The infraspecific primary author of an organism shall be specified. Refers to the first author, who published the infraspecific plant/animal name (of any infraspecific rank)

N/A N Text 2000

Infraspecific_primary_author_year

ORG.20 The infraspecific primary author year of an organism shall be specified. Refers to the year in which the first author published the infraspecific plant/animal name (of any infraspecific rank)

N/A N alphanumeric

10

Modification

MIXT.MOD

The modification section

N This section apply to:

Page 366: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 366/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..n)

The modification details shall be specified.

-Nucleic Acid -Protein -Polymer -Structurally Diverse Substances -Mixture This section shall be repeatable to describe each modification occurred on each residue modified.

Modification type

MOD.1.CV The type of the modification shall be provided based on a controlled vocabulary. EXAMPLE: Structural

CV [Modification Type]

Y Text 250

Residue modified

MOD.2.CV The name of the residue modified shall be described based on controlled vocabulary. NOTE: For virus or bacteria the value residue modified is = not applicable;

CV [Nucleotide Bases] OR [Amino acid] OR [Substance

Y Text 4000 If Substance_classification_type= protein, the CV [Amino acid] applies; If Substance_classification_type= nucleic acid, the CV [Nucleotide Bases] applies;

Page 367: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 367/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Name] If Substance_classification_type= polymer, the CV [Substance Name] applies. If Substance_classification_type= Structurally Diverse Substance or Mixture, the value residue modified is= not applicable

Residue_site

MOD.3 The position of specific residue undergone to modifications shall be described. Each residue shall be specified followed by a comma and space. For protein and nucleic acid, the number of the subunit followed by the number of the residue modified shall be specified. The underscore “_” shall be used as separator. EXAMPLE: 1_10 refers to the 10th residue on the 1st subunit Or

N Text 2000

Page 368: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 368/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

A1_10

physical_modification (0..n)

MOD.PM The physical modification section

N This section shall only apply if Modification type= Physical

Role PM.1.CV The role of the physical modification shall be provided based on a controlled vocabulary. EXAMPLE: inactivation, activation

CV [Modification]

Y Text 250

Number_of_parameters

PM.2 The number of parameter that is going to be described as result of the modification shall be provided.

No N Numeric

4 The value is automatically calculated.

Parameter (0..n)

PM.PARA The parameter section N The repeatability of this section is strictly related to the Value of the “Number_of_ Parameter” field. The section shall be repeated as many time as specified in the ‘number_of_parameters’ field.

Page 369: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 369/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Parameter

PARA.1.CV The parameter shall be described based on controlled vocabulary. EXAMPLE: time, temperature, pressure

CV [Parameter]

Y Text 250

Amount_type

PARA.2.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

PARA.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limi AMT.4.CV The prefix of the lower limit unit CV N alpha 250

Page 370: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 370/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_numerator_unit_prefix

of the substance shall be specified, where available.

[Unit Prefix]

numeric

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 371: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 371/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable.

N alphanumeric

250

Page 372: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 372/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Short, High (temperature)

structural_modification (0..n)

MOD.SM The structural modification section

N This section shall apply if Modification type= Structural This section is repeatable.

Structural_modification_type

SM.1.CV The type of the structural modification shall be described based on a controlled vocabulary

CV [Modification]

Y Text 250

Moiety (0..n)

SM.MOT The moiety section This section describes the moiety affected by the modification where applicable.

N

Moiety_Role

MOT.1.CV The role of the moiety shall be described based on a controlled vocabulary. EXAMPLE: antigen, linker, conjugate

CV [Role]

Y text 250

Moiety_name

MOT.2 The name of the moiety shall be provided.

CV [Substance

Y Text 4000

Page 373: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 373/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

If the substance name is not present in the Controlled Vocabulary, the moiety name shall be described as a free text.

Name]

Moiety_id

MOT.3 The unique identifier assigned to the substance representing the moiety based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Amount_type

MOT.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount

MOT.AMT The amount section N

Page 374: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 374/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..1) Quantity

Operator AMT.1.CV CV

[Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanume

250

Page 375: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 375/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

specified, where available.

[Unit Prefix] ric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 376: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 376/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

molecular fragment (0..n)

SM.MFRAG The molecular fragment section. This section describes the molecular fragment affected by the modification where applicable.

N

Role MFRAG.1.CV

The role of the molecular fragment shall be described based on a controlled vocabulary.

CV [Role]

Y Text 250

Page 377: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 377/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Molecular_fragment_id

MFRAG.2 The unique identifier for molecular fragment shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Molecular_fragment_name

MFRAG.3 The name for molecular fragment shall be specified.

CV [Substance Name]

Y Text 4000

Amount_type

MFRAG.4.CV

The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount

MFRAG.AMT

The amount section N

Page 378: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 378/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(0..1) Quantity

Operator AMT.1.CV CV

[Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_

AMT.7.CV The prefix of the lower limit unit of the substance shall be

CV

N alphanume

250

Page 379: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 379/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

denominator_unit_prefix

specified, where available.

[Unit Prefix] ric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 380: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 380/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

agent_modification (0..n)

MOD.AM The modification agent section. This section described the agent that caused the modification.

N

Agent_modification_type

AM.1.CV The type of the agent used for the modification shall be specified based on a controlled vocabulary. EXAMPLE: chemical, enzymatic

CV [Agent Modification Type]

Y text 250

Page 381: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 381/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Role AM.2.CV The role of the modification agent shall be specified based on a controlled vocabulary.

CV [Modification]

Y Text 250

Modification_agent

AM.3 The name of modifying agent shall be specified based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

Modification_agent_id

AM.4 The unique identifier of modifying agent shall be provided. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Modification_proce

AM.5.CV The modification process shall be specified based on a

CV

N Text

250

Page 382: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 382/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ss controlled vocabulary. EXAMPLE: UV irradiation

[Modification Process]

Amount_type

AM.6.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

AM.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 383: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 383/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_val

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

Page 384: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 384/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ue

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Page 385: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 385/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

mixture_constituent (2..n)

MIXT.MXCON

The mixture constituent section The substance constituting the mixture shall be described.

Y The section is mandatory if Substance_type_cv= Mixture

Constituent_id

MXCON.1 The unique identifier assigned to the constituent based on controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Constituent_name

MXCON.2 The name of the constituent of the mixture shall be described.

CV [Substance Name]

Y Text 4000

Constituent_requirement

MXCON.3.CV

The requirement of the constituent shall be described based on a controlled

CV [Requirement

N Text 250

Page 386: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 386/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

vocabulary. EXAMPLE: may be present

]

Page 387: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 387/485

4.3.7. SSI for Specified Substance Group 1

For Specified Substance Group 1, the SSI shall be described based on the following data elements:

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

specified_substance_group1

SPCFD.GP1 The specified substance group 1 section The identifying characteristics for the specified substance group 1 shall be specified.

The section is mandatory if Substance_type_cv= Specified_substance_group1

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used.

Page 388: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 388/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

Specified_substance_group1_id

GP1.1 The unique identifier assigned to the specified substance group1 shall be specified. NOTE: If a unique “Specified Substance ID” (EVCODE) has been assigned by the EMA, this “Specified Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Specified Substance ID” e. g. for the initial submission of the substance this data element is not required.

N Alphanumeric

12 In the absence of a unique “Specified Substance ID” e.g. for the initial submission of the specified substance this data element shall not be populated. The ID of the substance will be automatically assigned by the system once the message will be processed.

Specified_substance_group1_name

GP1.2 The name of the specified substance group 1 shall be provided in this field. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

N/A Y Text 4000

substance_name

COM.SNM The substance name section

Y

Page 389: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 389/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

(1..n)

This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology).

Page 390: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 390/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Official_name_status_chan

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally

Page 391: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 391/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

ge_date shall be only entered when name is changed. EXAMPLE: 2011-06-01

agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.

Official_name_juri

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-

CV

Y Text 3

Page 392: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 392/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

sdiction 1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

[Country Code]

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 393: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 393/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_code (0..n)

COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.

N

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Page 394: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 394/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Code_system_change_date

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information.

Y

Page 395: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 395/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 396: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 396/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of the substance.

Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Page 397: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 397/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship

Y

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Page 398: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 398/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Page 399: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 399/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Substance_classification_code

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.

N alphanumeric

250

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Page 400: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 400/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section.

CV [relationship type]

Y Text 250

Page 401: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 401/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: transporter, metabolic enzyme

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Page 402: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 402/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limi AMT.7.CV The prefix of the lower limit unit of CV N alpha 250

Page 403: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 403/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_ denominator_unit_prefix

the substance shall be specified, where available.

[Unit Prefix]

numeric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average AMT.14 The average amount or single value N Nume 10

Page 404: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 404/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

of the substance shall be specified.

ric

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 405: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 405/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

N text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 406: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 406/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 2000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source

RS.2.CV The type of the reference source shall be specified based on a controlled

CV

Y text 250

Page 407: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 407/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

_type vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary.

CV [Gene Element

Y Text 250

Page 408: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 408/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enhancer, promoter, silencer, terminator

Type]

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not.

Yes /No

Y Boolean

Page 409: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 409/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Yes or No values apply.

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance.

N This section does not apply when Substance_classification_type is equal to Specified Substance

Page 410: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 410/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor

Group 1, Specified Substance Group 2 and Specified substance group 3.

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Page 411: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 411/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane

CV [Target type]

N Text 250

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 412: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 412/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

constituent (1..n)

GP1.CON The constituent section The identifying characteristics of the constituent of the specified substance group 1 shall be specified. The section is repeatable to allow the description of: - the parent ID(s) of the specified substance group 1 that is always referring to Substance ID(s) - All the components of substances such as impurities, degradent, metabolite, active markers and solvent used in herbal preparations. NOTE: the constituent section shall be repeatable to describe multiple substances where each of the applicable parent IDs shall be

Y The section is mandatory if Substance_type_cv= Specified_substance_group1 It is mandatory to specify at least one constituent section with role = parent ID;

Page 413: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 413/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

provided.

Substance_id

CON.1 The unique identifier assigned to the substance that constitutes the specified substance group 1 shall be defined based on controlled vocabulary. For herbals, the constituents refers to herbal markers or the herbal substance (s) which is present in the herbal preparation (e.g. Sennosides A; Senna Acutifolia et Senna Angustifolia leaf tincture) For vaccines, the constituents refer to adjuvant (s). For multiple substances, the constituent refers to the substances complexed together to form the final multiple substance (e.g. Insulin human and protamine are constituents of the Insulin Isophane) NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial

CV [Substance Name]

N Alphanumeric

12

Page 414: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 414/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

submission of the substance this data element is not required.

Substance_name

CON.2 The name of the substance which is the constituent of the specified substance group 1 shall be described.

CV [Substance Name]

Y Text 4000

Substance_role

CON.3.CV The role of the substance in the specified substance shall be described based on a controlled vocabulary. An impurity component is not described in the Specified Substance Group 1. The parent ID of a specified substance group 1 shall always be specified. EXAMPLE: active marker, component, degradent, metabolite, active moiety

CV [Constituent Role]

Y Text 250 The constituent section shall be present as mandatory with a role=Parent ID

Amount_type

CON.4.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

CON.AMT The amount section N

Page 415: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 415/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limi AMT.8 The higher limit value of the N Nume 10

Page 416: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 416/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_numerator_value

substance shall be specified, where available.

ric

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit

N alphanumeric

250

Page 417: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 417/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

Prefix]

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Property (0..n)

GP1.PROP The property section The characteristics of the property shall be described.

N

Property_type

PROP.1.CV The type of property shall be specified based on a controlled vocabulary. EXAMPLE: physical, chemical, enzymatic, immunological

CV [Property Type]

Y Text 250

Property_name

PROP.2.CV The name of property shall be specified based on a Controlled Vocabulary.

CV [Parameter]

Y Text 250

Substance_id

PROP.3 The identifier of the substance related to a defining property shall be described where applicable and based on controlled vocabulary.

CV [Substance Name]

N Alphanumeric

12

Page 418: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 418/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: solubility in Water, Water ID shall be specified NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Substance_name

PROP.4 The name of the substance related to a defining property shall be described where applicable. EXAMPLE: solubility in Water, Water shall be specified

CV [Substance Name]

N Text 4000

Amount_type

PROP.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (1..1)

PROP.AMT The amount section Y

Quantity Operator

AMT.1.CV CV

N text 250

Page 419: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 419/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

[Quantity Operator]

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

Page 420: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 420/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a

CV

N alphanume

250

Page 421: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 421/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

controlled vocabulary.

[Unit of Measure]

ric

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

physical_form (0..n)

GP1.PF The physical form section The characteristics of the physical form of the specified substance shall be described. It is required to provide the physical form information when applicable.

N

Physical_state

PF.1.CV The physical form shall be specified based on a controlled vocabulary. EXAMPLE: solid, liquid

CV [Physical state]

Y Text 250 If a physical_form of the specified substance is applicable, the “physical_state” should be specified.

Physical_form_type

PF.2.CV The physical form type shall be specified based on a controlled vocabulary. EXAMPLE: crystaline, amorphous, tincture, dry, extract

CV [Physical Form]

Y Text 250

Amount_type

PF.3.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

Page 422: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 422/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

amount (0..1)

PF.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limi AMT.7.CV The prefix of the lower limit unit of CV N alpha 250

Page 423: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 423/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

t_ denominator_unit_prefix

the substance shall be specified, where available.

[Unit Prefix]

numeric

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average AMT.14 The average amount or single value N Nume 10

Page 424: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 424/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

of the substance shall be specified.

ric

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (0..n)

GP1.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 425: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 425/485

SSI level Data Element Name

Ref Code Data Element Description and Notes

CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Page 426: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 426/485

4.3.8. SSI for Specified Substance Group 2

For Specified Substance Group 2, the SSI shall be described based on the following data elements:

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

specified_substance_group2

SPCFD.GP2

The specified substance group 2 section The identifying characteristics for the specified substance group 2 shall be specified.

The section is mandatory if Substance_type_cv= Specified_substance_group2

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

Language

SUB.LANG The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be

Page 427: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 427/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

Specified_substance_group2_id

GP2.1 The unique identifier assigned to the specified substance group2 shall be specified. NOTE: If a unique “Specified Substance ID” (EVCODE) has been assigned by the EMA, this “Specified Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Specified Substance ID” e. g. for the initial submission of the substance this data element is not required.

N Alphanumeric

12

Specified_substance_group2_name

GP2.2 The name of the specified substance group 2 shall be described. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

N/A Y Text 4000

Page 428: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 428/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Parent_substance_id

GP2.3 The unique identifier assigned to the substance that is the parent of the specified substance shall be provided based on controlled vocabulary. The ID of the parent for the specified substance group 1 may refer to either a substance ID or a specified substance group 1 ID. NOTE: If a unique “ID” (EVCODE) has been assigned by the EMA, this “ID” shall be specified based on the Substance Name CV. In the absence of a unique “ID” e. g. for the initial submission of specified substance and parent substance, the name of the parent substance shall be specified.

CV [Substance Name]

Y Alphanumeric

4000

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.:

Y

Page 429: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 429/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EMA/720247/2011) shall be followed.

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary. EXAMPLE: Official name, Code

CV [Substance Name Type]

Y text 250

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is

Page 430: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 430/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name (0..n)

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis.

Page 431: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 431/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: 2011-06-01

It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domain (1..n)

ON.DOM Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.

Official_name_juri

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1

CV

Y Text 3

Page 432: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 432/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

sdiction alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

[Country Code]

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 433: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 433/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_code (0..n)

COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.

N

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV

Y

Text 250

Page 434: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 434/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

[Code System]

Code_system_id

SC.3.CV The identifier for the code system shall be provided based on a controlled vocabulary.

CV [Code System]

N alphanumeric

12

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Code_system_change_date

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Commen SC.6 Any comment can be provided in this N Text 4000

Page 435: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 435/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

t field, if necessary.

reference_source (1..n)

SC.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 436: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 436/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of the substance.

Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest

Page 437: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 437/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship

Y

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV The domain of the substance classification shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceuticals

CV [Domain]

Y text 250

Page 438: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 438/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Substance_Classification

SCLF.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Substance_classification_type

SCLF.3.CV The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field. EXAMPLE: One polymer combined in a

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Page 439: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 439/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

protein, Specified_classification_type =mixture

Substance_classification_code

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.

N alphanumeric

250

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source

RS.2.CV The type of the reference source shall be specified based on a controlled

CV

Y text 250

Page 440: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 440/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

_type vocabulary. EXAMPLE: INN

[Source]

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship (0..n)

RI.REL The substance relationship This section shall provide information related to relationship of a substance, where this is applicable.

N

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled

CV

Y Text 250

Page 441: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 441/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

[relationship type]

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Substance_name

REL.4 The substance name shall be specified.

CV

Y text 4000 Mandatory when there is a “substance relationship”

Page 442: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 442/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

[Substance Name]

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_numerator_unit_prefix

AMT.4.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Low_limit_denominator_val

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Page 443: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 443/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

ue

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_

AMT.12.CV The higher limit unit of the substance shall be specified, where available.

CV

N alphanume

250

Page 444: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 444/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

denominator _unit

[Unit of Measure]

ric

High_limit_ denominator_unit_prefix

AMT.13.CV The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a

Y

Page 445: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 445/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

“Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Page 446: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 446/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 2000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source

GN.RS The reference source section This section describes the reference

Y

Page 447: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 447/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

(1..n) source information. For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34

N/A N text 2500

Page 448: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 448/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Literature reference: Encycl. 3: 429 (1792)

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

CV [Substance Name]

N Alphanumeric

12

Gene_element_na

GE.3 The specific gene element name shall be described based on a controlled

CV

Y Text 4000

Page 449: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 449/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

me vocabulary.

[Substance Name]

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 450: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 450/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary.

CV [Target

Y Text 4000

Page 451: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 451/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: single substance, an enzyme type

Gene]

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary. EXAMPLE: enzyme, receptor, membrane

CV [Target type]

N Text 250

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Page 452: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 452/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Manufacturing (1..1)

GP2.MANU The manufacturing section The main characteristics in relation to the manufacturing of the substance shall be specified.

Y The section is mandatory if Substance_type_cv= Specified_substance_group2

Page 453: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 453/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Manufacturer_id

MANU.1 The unique code used to track manufacturers shall be provided.

N/A Y Alphanumeric

12

Manufacturer_name

MANU.2.CV

The name of the manufacturer of the specified substance shall be provided.

CV [Manufacturer Name]

Y Text 2000

Manufacturing_type

MANU.3.CV

The type of the manufacturer shall be provided based on a controlled vocabulary.

CV [Manufacturing Type]

Y Text 250

Production_method_type

MANU.4.CV

The type of the production method shall be provided based on a controlled vocabulary. EXAMPLE: synthetic, extractive, semisynthetic, biosynthetic, etc

CV [Production Method] Or [Herbal Production Method]

Y Text 250 When Substance_class_subtype= Herbal, the [Herbal Production Method] CV applies. For all the other subtype, [Production Method] CV applies.

Production_system_type

MANU.5.CV

The type of the production system shall be provided based on a controlled vocabulary. EXAMPLE: cell line, animal, tissue, egg

CV [Production System Type]

Y Text 250

Production_syste

MANU.6.CV

The production system description shall be provided when available.

CV

N Text 250

Page 454: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 454/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

m EXAMPLE: cho cell, goat, bovine lungs The production system does not apply to Herbals.

[Production System]

reference_source (1..n)

MANU.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 455: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 455/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

4.3.9. SSI for Specified Substance Group 3

For Specified Substance Group 3, the SSI shall be described based on the following data elements:

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

specified_substance_group3

SPCFD.GP3

The specified substance group 3 section The identifying characteristics of the specified substance group 3 shall be provided.

The section is mandatory if Substance_type_cv= Specified_substance_group3

Page 456: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 456/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Substance_Classification

COM.2.CV Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250

Language

SUB.LANG

The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

Page 457: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 457/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Specified_substance_group3_id

GP3.1 The unique identifier assigned to the specified substance group2 shall be specified. NOTE: If a unique “Specified Substance ID” (EVCODE) has been assigned by the EMA, this “Specified Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Specified Substance ID” e. g. for the initial submission of the substance this data element is not required.

N Alphanumeric

12

Specified_substance_group3_name

GP3.2 The name of the specified substance group 3 shall be described. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

N/A

Y Text 4000

Parent_substance_id

GP3.3 The unique identifier assigned to the substance that is the parent of the specified substance shall be provided based on controlled vocabulary. The ID of the parent for the specified substance group 3 may refer to either a substance ID or specified substance

CV [Substance Name]

Y Alphanumeric

4000

Page 458: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 458/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

group 1 ID. NOTE: If a unique “ID” (EVCODE) has been assigned by the EMA, this “ID” shall be specified based on the Substance Name CV. In the absence of a unique “ID” e. g. for the initial submission of specified substance and parent substance, the name of the parent substance shall be specified.

substance_name (1..n)

COM.SNM The substance name section This section contains the set of elements for the description of the name of the substance. The latest version of the Naming Conventions document (Ref. Doc.: EMA/720247/2011) shall be followed.

Y

Substance_name

SNM.1 The name of the substance shall be specified.

Y Text 4000

Substance_name_type

SNM.2.CV The type of the name shall be specified based on a controlled vocabulary.

CV [Substance

Y text 250

Page 459: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 459/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Official name, Code

Name Type]

Language

SNM.3.CV The language used to provide the structure substance information shall be specified according to ISO 639-2 alpha-3 codes. EXAMPLE: eng – English deu (T) - German

CV [Language]

Y text 3 Note: ISO 639-2 is the alpha-3 code in Codes for the representation of names of languages-- Part 2. There are 21 languages that have alternative codes for bibliographic or terminology purposes. In those cases, each is listed separately and they are designated as "B" (bibliographic) or "T" (terminology). For the purpose of describing “Language”, “T” shall be used. In all other cases there is only one ISO 639-2 code. Multiple codes assigned to the same language are to be considered synonyms.

official_name

SNM.ON The official name section N If “Official Name” has been specified in “Substance_Name_Type” this

Page 460: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 460/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

(0..n) section is mandatory. For any other name type, the section is present as not mandatory.

Official_name_type

ON.1.CV The type of the official name shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Official_name_status

ON.2.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Official_name_status_change_date

ON.3 The change date of the status of the official name shall be specified in line with the ISO 8601 date format, which shall be only entered when name is changed. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

official_name_domai

ON.DOM Y If “Official Name” has been specified in “Substance Name

Page 461: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 461/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

n (1..n)

Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Domain”.

Official_name_domain

DOM.1.CV The domain of the name shall be provided based on a controlled vocabulary. EXAMPLE: Human Pharmaceutical

CV [Domain]

Y Text 250

official_name_jurisdiction (1..n)

ON.JUR The jurisdiction of the official name section

Y If “Official Name” has been specified in “Substance Name Type” this section is mandatory. Each “Official Name” shall have at least one “Official Name Jurisdiction”.

Official_name_jurisdiction

JUR.1.CV The jurisdiction of the official name shall be provided based on ISO 3166-1 alpha-2 codes with two exceptions: EL (not GR) is used to represent Greece, and UK (not GB) is used to represent the United Kingdom. For the European Union EU shall be used.

CV [Country Code]

Y Text 3

Page 462: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 462/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

reference_source (1..n)

SNM.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 463: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 463/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_code (0..n)

COM.SC The substance code section This section describes the specific code(s) within one or more available code system(s) that apply to a substance.

N

Code SC.1 The specific code (the value) with regard to a referenced code system shall be provided. NOTE: InChI is not considered a code and shall be specified within the structure description.

N/A Y alphanumeric

500

Code_system

SC.2.CV The code system shall be specified based on a controlled vocabulary.

CV [Code System]

Y

Text 250

Code_sys SC.3.CV The identifier for the code system shall CV N alpha 12

Page 464: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 464/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

tem_id be provided based on a controlled vocabulary.

[Code System]

numeric

Code_system_status

SC.4.CV The status of the code system shall be specified based on a controlled vocabulary. EXAMPLE: current, proposed.

CV [Status]

Y text 250

Code_system_change_date

SC.5 The change date of the code system shall be specified in line with the ISO 8601 date format, where applicable. EXAMPLE: 2011-06-01

ISO 8601 date format

N alphanumeric

10 This applies only when the code is changed, so it is not applicable for initial submission. ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Comment

SC.6 Any comment can be provided in this field, if necessary.

N Text 4000

reference_ SC.RS The reference source section Y

Page 465: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 465/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

source (1..n)

This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 466: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 466/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

version (1..n)

COM.VER The version section This section shall provide information on the version of the substance.

Y Where no “Version Number” and “Effective Date” have been assigned by an authority source, the version number shall be set as 0 with the date set as the date of initial submission of the substance.

Version_number

VER.1 The number of the version of the SSI shall be provided.

N/A Y numeric

4

Effective_date

VER.2 The date when the SSI was effective shall be provided in line with the ISO 8601 date format. This shall be defined when the SSI is generated or modified.

ISO 8601 date format

N alphanumeric

10 ISO 8601 advises numeric representation of dates and times on an internationally agreed basis. It represents elements from

Page 467: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 467/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

the largest to the smallest element: e.g. year-month-day YYYY-MM-DD

Change_made

VER.3 The description of the updates or changes of the SSI shall be specified. The field will be left empty when first insert of substance.

N/A

N text 4000

reference_information (1..1)

COM.RI The reference information section This section is used to provide details about: - substance classification - target - gene from which proteins are derived - substance relationship

Y

Comment

RI.1 Any comment can be provided in this field, if necessary.

N Text 4000

substance_classification (1..n)

RI.SCLF The substance classification

Y One or more “Substance Classifications” shall be specified.

Domain SCLF.1.CV

The domain of the substance classification shall be provided based on a controlled vocabulary.

CV [Domain]

Y text 250

Page 468: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 468/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: Human Pharmaceuticals

Substance_Classification

SCLF.2.CV

Type of substance based on a controlled vocabulary. EXAMPLE: Single, Mixture

CV [Substance Class]

Y Text 250 The information provided in this field shall be automatically populated based on the information provided in the Substance_Classification field (COM.2.CV).

Substance_classification_type

SCLF.3.CV

The type of the substance shall be provided based on a controlled vocabulary. NOTE: When Substance_Classification=mixture and the substances that are forming the mixture are of the same class, the class of those substances shall be specified in this field. EXAMPLE: two chemicals forming the mixture, specified_classification_type = chemical If the substances that are forming the mixture are of a different class, the value ‘mixture’ shall be specified in this field.

CV [Substance Type] [Specified substance Type]

Y Text 250 When Substance_Classification= Single or mixture, the [Substance Type] CV applies. When Substance_Classification=Specified substance the [Specified Substance Type] CV applies.

Page 469: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 469/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: One polymer combined in a protein, Specified_classification_type =mixture

Substance_classification_code

SCLF.4 The code of the classification type where applicable shall be specified based on a controlled vocabulary.

N alphanumeric

250

subtype (1..n)

SCLF.ST The subtype section Y

Substance_class_subtype

ST.1.CV The sub-type of the classification shall be described based on a controlled vocabulary. EXAMPLE: Vaccine, Herbal, Multiple Substances

CV [Substance subtype]

Y Text 250

reference_source (1..n)

SCLF.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Page 470: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 470/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

substance_relationship

RI.REL The substance relationship This section shall provide information related to relationship of a substance,

N

Page 471: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 471/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

(0..n)

where this is applicable.

Relationship

REL.1.CV The relationship of a substance shall be defined based on a controlled vocabulary. NOTE: Target and gene elements are not to be specified in this section. EXAMPLE: transporter, metabolic enzyme

CV [relationship type]

Y Text 250

Interaction_type

REL.2.CV The type of interaction shall be specified based on a controlled vocabulary, where applicable. EXAMPLE: covalent

CV [Interaction Type]

N Text 250

Substance_id

REL.3 The substance identifier, for which the relationship is specified, shall be described. NOTE: If a unique “Substance ID” (EVCODE) has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not

CV [Substance Name]

N Alphanumeric

12

Page 472: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 472/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

required.

Substance_name

REL.4 The substance name shall be specified.

CV [Substance Name]

Y text 4000 Mandatory when there is a “substance relationship”

Amount_type

REL.5.CV The type of the amount of the substance shall be specified using a controlled vocabulary.

CV [Amount Type]

N Text 250

amount (0..1)

REL.AMT The amount section N

Quantity Operator

AMT.1.CV CV [Quantity Operator]

N text 250

Low_limit_numerator_value

AMT.2 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_numerator_unit

AMT.3.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limi AMT.4.CV The prefix of the lower limit unit of the CV N alpha 250

Page 473: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 473/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

t_numerator_unit_prefix

substance shall be specified, where available.

[Unit Prefix]

numeric

Low_limit_denominator_value

AMT.5 The lower limit value of the substance shall be specified, where available.

N Numeric

10

Low_limit_ denominator _unit

AMT.6.CV The lower limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

Low_limit_ denominator_unit_prefix

AMT.7.CV The prefix of the lower limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

High_limit_numerator_value

AMT.8 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_numerator_unit

AMT.9.CV The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_numerator_unit_prefix

AMT.10.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Page 474: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 474/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

High_limit_denominator_value

AMT.11 The higher limit value of the substance shall be specified, where available.

N Numeric

10

High_limit_ denominator _unit

AMT.12.CV

The higher limit unit of the substance shall be specified, where available.

CV [Unit of Measure]

N alphanumeric

250

High_limit_ denominator_unit_prefix

AMT.13.CV

The prefix of the higher limit unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Average

AMT.14 The average amount or single value of the substance shall be specified.

N Numeric

10

Prefix AMT.15.CV

The prefix of the average unit of the substance shall be specified, where available.

CV [Unit Prefix]

N alphanumeric

250

Unit AMT.16.CV

The applicable unit for the average shall be specified based on a controlled vocabulary.

CV [Unit of Measure]

N alphanumeric

250

Non_numeric_value

AMT.17 The non numeric value shall be specified when a numeric value it is not applicable. EXAMPLE: Short, High (temperature)

N alphanumeric

250

Page 475: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 475/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

reference_source (1..n)

REL.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 476: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 476/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

gene (0..n)

RI.GN The gene section This section shall provide a description of the gene in relation to a substance, where applicable. The gene section refers only to gene that is the origin of the substance (protein).

N This section does not apply when Substance_classification_type is equal to chemical, Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Gene_sequence_origin

GN.1.CV The common name for the organism from which the final gene sequence originated shall be specified based on a controlled vocabulary. NOTE: it applies primarily to proteins.

CV [Organism Name]

N Text 2000

Gene_id GN.2 The identifier of the gene shall be provided based on a controlled vocabulary. E.g.: YP_299723.1

CV [Gene Name]

N alphanumeric

12

Page 477: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 477/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Gene_name

GN.3 The complete name given for a gene shall be provided based on a controlled vocabulary. E.g.: hIL-10 gene

CV [Gene Name]

Y Text 4000

reference_source (1..n)

GN.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Page 478: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 478/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Gene_element (0..n)

RI.GE The gene element section N

Gene_element_type

GE.1.CV The type of the gene element shall be specified based on a controlled vocabulary. EXAMPLE: enhancer, promoter, silencer, terminator

CV [Gene Element Type]

Y Text 250

Gene_element_id

GE.2 The unique identifier for the gene element shall be specified based on a controlled vocabulary. NOTE: If a unique “Substance ID” (EVCODE)

CV [Substance Name]

N Alphanumeric

12

Page 479: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 479/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

has been assigned by the EMA, this “Substance ID” shall be specified based on the Substance Name CV. In the absence of a unique “Substance ID” e. g. for the initial submission of the substance this data element is not required.

Gene_element_name

GE.3 The specific gene element name shall be described based on a controlled vocabulary.

CV [Substance Name]

Y Text 4000

reference_source (1..n)

GE.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary.

CV [Source]

Y text 250

Page 480: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 480/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: INN

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Target (0..n)

RI.TRG The target section This section shall provide information on the target substance. It refers for genes to the target of the protein expressed by that gene. For all the other substances type it refers

N This section does not apply when Substance_classification_type is equal to Specified Substance Group 1, Specified Substance Group 2 and Specified substance group 3.

Page 481: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 481/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

to the substrate of the substance. EXAMPLE: enzyme, protein/channel, receptor

Target_gene_id

TRG.1 The identifier of the target gene shall be provided.

CV [Target Gene]

N alphanumeric

12

Target_gene_name

TRG.2 The target gene name shall be specified based on a controlled vocabulary. EXAMPLE: single substance, an enzyme type

CV [Target Gene]

Y Text 4000

Interaction_type

TRG.3.CV The type of interaction shall be specified based on a controlled vocabulary. EXAMPLE: Inhibition

CV [Target interaction type]

Y text 250

Target_organism_type

TRG.4.CV The type of target organism shall be specified based on a controlled vocabulary. EXAMPLE: human, viral

CV [Organism type]

N Text 250

Target_type

TRG.5.CV The target type shall be specified based on a controlled vocabulary.

CV [Target

N Text 250

Page 482: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 482/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

EXAMPLE: enzyme, receptor, membrane type]

reference_source (1..n)

TRG.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 483: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 483/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500

Grade (1..1)

GP3.GRD The grade section The characteristics of the grade of the substance shall be specified.

Y The section is mandatory if Substance_type_cv= Specified_substance_group3

Grade_type

GRD.1.CV The type of the grade shall be provided based on a controlled vocabulary.

CV [Grade Type]

Y Text

250

Grade_name

GRD.2 The name of the grade as specified in the monograph shall be provided. EXAMPLE: purified water, water for injection, Insulin Human Injection

N/A Y Text 4000

Grade_reference_source

GRD.3 The specific reference to a monograph source shall be provided. EXAMPLE: For Insulin zinc injectable suspension (crystalline) monograph. Ph. Eu. Ed 7th

N/A

Y Text

4000

Page 484: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 484/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

2011 (7.2)

reference_source (1..n)

GRD.RS The reference source section This section describes the reference source information. For each “Substance Name” a “Reference Source” shall be specified.

Y

Public_domain

RS.1 It shall be specified if the reference source information is public or not. Yes or No values apply.

Yes /No

Y Boolean

Reference_source_type

RS.2.CV The type of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: INN

CV [Source]

Y text 250

Reference_source_class

RS.3.CV The class of the reference source shall be specified based on a controlled vocabulary. EXAMPLE: Regulatory submission

CV [Source Class]

Y text 250

Reference_source_id

RS.4 The code or number referring to the reference source shall be specified.

N/A N alphanumeric

12

Page 485: Detailed guidance on the electronic submission of ... · 9/1/2011  · Detailed guidance on the electronic submission of information on medicinal products for human use by marketing

Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the European Medicines Agency in accordance with Article 57(2), second subparagraph of Regulation (EC) No. 726/2004

EMA/721630/2011 Page 485/485

SSI level Data Element Name

Ref Code Data Element Description and Notes CV Reference

Mandatory

Type Field Length

Business Rules

Reference_source_citation

RS.5 The textual description of the reference source within the literature or regulatory document shall be described. EXAMPLE: Ph.E. 7.1, p.34 Literature reference: Encycl. 3: 429 (1792)

N/A N text 2500